Science

Children's Health Defense: 1 in 30 U.S. Kids Diagnosed With Autism in 2020 — What’s Behind the Surge?

8252466D-6638-47E5-AF98-EB1F28B4267CNote: Thank you to Children's Health Defense for including Age of Autism's Managing Editor Kim Rossi for a behind the front lines look at what the increase means and "going there." However, Kim Rossi, managing editor of Age of Autism, found Siegel’s reasons unconvincing and inadequate. She sure did.

1 in 30 U.S. Kids Diagnosed With Autism in 2020 — What’s Behind the Surge?

Roughly 1 in 30 children and adolescents ages 3 to 17 were diagnosed with an autism spectrum disorder in 2020, according to a JAMA Pediatrics research letter, which also referenced a new study showing a 53% increase in ASD in young Americans since 2017.

By  Suzanne Burdick, Ph.D.

Roughly 1 in 30 — 3.49% — of children and adolescents ages 3 to 17 were diagnosed with an autism spectrum disorder (ASD) in 2020, according to a JAMA Pediatrics research letter published this month by a team of researchers in China.

The letter also referenced a new study showing a 53% increase in ASD in American young people since 2017.

The researchers used data, gathered in 2019 and 2020, from the U.S. National Health Interview Survey (NHIS), which collects health-related information via household interviews conducted by the U.S. Census Bureau.

During the NHIS interviews, a parent or guardian reported on ASD diagnoses made by a physician or other healthcare professional.

Of the 12,554 individuals ages 3 to 17 surveyed in 2019 and 2020, 410 were reported to have a diagnosis of ASD.

The research team, including corresponding author Dr. Wenhan Yang, M.D., Ph.D., from the School of Public Health, Guangdong Pharmaceutical University in China, compared the 2019 and 2020 NHIS results to NHIS results from the years 2014 to 2018.

“We found the prevalence of ASD increased from 2014 to 2016, decreased from 2016 to 2017, and then increased again from 2017 to 2020,” Yang and colleagues wrote.  Read the full article at Children's Health Defense.


Autism Up More Than 50%

PoppycockThe study’s authors suggest that the United States typically has higher autism rates than the rest of the world. The team believes this is due to better screening and diagnosis.

From Safeminds:

July 11, 2022
New Study Reports that ASD Rates Jumped More Than 50% from 2017 to 2020

A recent research letter published in JAMA Pediatrics shows that the overall autism spectrum disorder (ASD) rate for American children ages 3 to 17 in 2019 and 2020 has risen to 3.14%. When separating data by year, the results show the autism prevalence rate was 2.79% in 2019. Then the rate explodes in 2020 when it jumps to 3.49% or 1 in 30 children. According to the study, nearly 5% of young American boys have autism, compared to just under 2% of girls. This research comes from a team of scientists from Guangdong Pharmaceutical University in China who used statistics from the National Health Interview Survey (NHIS), which collects information through household interviews. NHIS data includes parental reports of an ASD diagnosis given directly to census bureau employees administering the survey. Shockingly, autism rates jumped by more than 50% from 2017 to 2020, according to NHIS statistics. The study’s authors suggest that the United States typically has higher autism rates than the rest of the world. The team believes this is due to better screening and diagnosis. This new 1 in 30 statistic reflects a far higher rate than the CDC’s Autism and Developmental Disabilities Monitoring Network (ADDM), which announced last December that 1 in 44 American children hold an autism diagnosis. Since ADDM rates are based on eight-year-old children and typically take four years to process and publish, this current study is more timely and possibly more accurate. Additionally, the NHIS data used a larger age cohort than the ADDM network, and this research team took only two years to process and publish their findings.  Read more here at Safeminds.


British Drug Regulator (MHRA) Develops, Manufactures and Sells Its Own Biological Products Including Vaccines

John Stone UK ColumnBy John Stone

(UPDATE) It is disturbing to have confirmed by Megan Redshaw’s article in The Defender  yesterday  (June 27) that it will be the Gates/WHO/MHRA polio vaccine which is being rolled out in the UK which according to Dr Mark Bailey is not “proved” or in layman’s language “experimental”. Obviously, the Salk oral polio vaccine has not been in use for many years and his comparison is misleading and inappropriate , and we do not know why this product is preferred to the standard inactivated product (IPV).

This is a follow on to a UK Column Report last week with excellent analysis by retired nurse Debi Evans and News anchor Brian Gerrish which focused on the board meeting of the MHRA of Tuesday June 21. There were many disturbing features in the report which runs from 1.06.50 on the link, but one really surprising fact which emerged - and I have been following the MHRA closely since at least 2004 - is that they combine purported role as a regulator of the biologics industry with developing its own biological products and trading with the industry: this happens through its subsidiary since 2013 the National Institute of Biological Standards and Control (NIBSC) though it’s  not immediately clear how long NIBSC has traded its own biological products.

Of particular relevance is that coincidentally with this meeting a new polio scare was being launched in the UK - no one as of this present time has been diagnosed with polio but polio has been detected in a North East London sewer. It is therefore fascinating to follow the conversation (which I have transcribed as best I can) between to the interim director of NIBSC, Mark Bailey, and Stephen Lightfoot, Chairman of MHRA (at 1.22.18):

Bailey:

Significant investment by NIBSC and also its partners the Gates foundation and of course its part of   the WHO lab in (indecipherable) and of course basically premiere eradication. There are three strains of polio and the team at NIBSC developed three different vaccines. It happens that strain two is the one that has been deployed most in clinical trials in Africa and it's listed product by the WHO which mean it can be used in emergency situations even though it is not proved. We are now moving to clinical trials with the other two strains as well, so it's very exciting: it's a huge huge combination: its effect is that this vaccine cannot revert. So the Salk vaccine which was used with most of us as kids there was always a low chance of it reverting back to wild type which means things like polio begins to appear in the population. This is a great leap forward here because it can't revert so basically its much safer.

Lightfoot:

Again I think this is a great example of how the MHRA is different from other regulators around the world because we have NIBSC or National Institute for Biological Standards and Control where do some basic looking at fundamental research and this is a good example of the work that we are doing in that area and the public health benefit it can have internationally and not just in the UK  so I think actually as regulator we've got some really important you know constituent parts that actually make us a very strong and capable organisation.

The reality of this is if the MHRA ever was functionally a “regulator” it has abandoned this role to facilitate business, it even trades with industry in Coronavirus spike-protein. This was emphasised in an earlier UK Column report when MHRA CEO June Raine excruciatingly discussed transforming the MHRA in 2020 from being “a regulator to an enabler” (at 47.30). And of course it is a whole different level of concern if the MHRA not only received research funding from the Gates Foundation as has previously been identified but is actually in business with them (and the WHO). Of course, the pretext was that there was an emergency and this was in the most formal bureaucratic terms an outright lie.

Continue reading "British Drug Regulator (MHRA) Develops, Manufactures and Sells Its Own Biological Products Including Vaccines" »


53 Years of Knowledge: Vaccination and Chronic Disease

Truthfyl gentle fearlessImagine if doctors around the world acknowledged and fought to end vaccine injury. Wouldn't that be something? Instead, they actively work to deny and gaslight patients and their families.  Start paying attention to obituaries and articles about young people, including children, dying of natural causes and "peacefully." Dr. Moskowitz is truthful, gentle (I've had the privilege of meeting him) and fearless.

###

You can find a .pdf of this post here. Download Dr Richard Moskowitz Vaccination and Chronic Disease  Dr. Moskowitz meticulously formatted and cited his article, however, the blog platform is not always kind to formatting. I encourage you to read the .pdf.  Thank you.

By Richard Moskowitz, M. D.

In my 53 years as a family doctor, I cared for a large number of children who were adversely affected by many different vaccinations, with diagnoses as varied as an average pediatric practice.  Yet they all reacted in closely similar fashion, hinting at something important in the nature of chronic disease, the great riddle that has confounded physicians since the earliest times.  My plan is to begin with a summary of my own clinical experience, together with pertinent findings in the scientific literature, and then explore the questions it raises about chronicity itself, a dysfunction that somehow manages to insinuate itself into our everyday physiology, achieves in effect a new "normal" of healthy and diseased modes co-existing side-by-side in place of the old, and resists cure by perpetuating itself over the lifetime.  With all that in mind, I'll finish with the COVID to bring everything up date, followed by a brief epilogue on the special vantage point of clinical practice.

1.

Chronic disease is everywhere.

Always a troubling enigma to physicians, chronic diseases have become so prevalent in in recent decades that they now command a preponderance of the time, space, and energy of most practicing physicians in the United States and the developed world.  As far back as 2008, the CDC surveyed the incidence of six prominent types in the United States -- diabetes, cardiovascular disease, COPD, asthma, cancer, and arthritis -- and found that

60% of all adults had been diagnosed with 1 or more of them, as had

78% of those 55 and older, and

85.6% of those 65 and older,

and that

40% of all adults had been diagnosed with 2 or more, as had

47% of those 55 and older, and

56% of those 65 and older.1

Since then, the fractions of our population affected by the most common ones have been estimated as follows, taking them one by one:

asthma, COPD, and chronic lung disease - 15% of all adults2,3                
arthritis - 23% of all adults4
hypertension - 33% of all adults, 76% of ages 75-845          
obesity - 42% of all adults6                 
diabetes - 10% of all adults7                 
chronic kidney disease - 15% of all adults8                              
dementia - 14% by age 719                                  
some form of cancer - 50% of males and 33% of females at some point in their lifetime10  

Although these figures have been steadily increasing throughout the industrialized world, the United States leads all other countries by a considerable margin, with by far the lowest life expectancy, despite spending the most per capita on health care.11

Continue reading "53 Years of Knowledge: Vaccination and Chronic Disease" »


Gut Science Was Slower Than A Colon After Surgery

Microbiome7Dr. Andy Wakefield thrust the gut connection into the spotlight more than 20 years ago. "Science" is slower than a colon after surgery. And often treats the originators like.....  From Safeminds:

June 13, 2022

Gut Bacteria Alterations Are Dependent on Offspring’s Sex

To prevent newborn sepsis caused by maternal Group B Streptococcus exposure, antibiotic use was promoted during labor and delivery starting in the 1990s. Since then, the use of prophylactic antibiotics given to laboring mothers has increased to more than 30% of all deliveries in the United States. However, this practice was implemented before our present-day and still emerging understanding of the microbiota’s important role in many aspects of health. Recently, researchers at the MIND Institute published a study investigating the effect of antibiotics administered to pregnant mice on offspring gut microbiome composition and metabolic capabilities. The researchers also investigated how these microbiota changes can influence the offspring’s immune responses. The study’s design involved administering a broad-spectrum antibiotic orally to pregnant mice during late gestation through birth. Post-birth, bacterial DNA was taken from offspring fecal samples and was then sequenced and analyzed. The offspring’s serum and brain tissue cytokine levels were also analyzed. The results showed that the antibiotic cocktail given to the pregnant mice produced significant diversity and taxonomic changes in their offspring’s microbiome. Also altered in the offspring were genomic and metabolic pathways. Interestingly, an increased Firmicutes/Bacteroidetes (F/B) ratio was found in female offspring but not males. An increased F/B ratio is associated with dysbiosis and metabolic disorders. The MIND Institute researchers concluded that maternal antibiotic exposure could produce long-lasting effects on the offspring’s gut microbiome and neuroimmune responses. They believe their findings demonstrate how important the role of the early microbiome is in the development of gastrointestinal and immune systems. 

Original Study


The British Government, the World Health Organization and the Global Coup of 2020

UK lockdownBy John Stone

In March 2020 the British Government decided to impose lockdown on the determination of the WHO against the advice of its own medical experts including Sir Chris Whitty - the experts then followed the policy, subordinating their judgment to the outside agency. These events anticipated the WHO’s recent and continuing attempts to formalise global supremacy in health, and demonstrates the arbitrariness and chaos which will inevitably follow 

I am trying to understand the events of March 2020 in the light of an answer to a recent Freedom of Information Request. Why and how was it that four days before lockdown was imposed on March 23 the four Chief Medical Officers of the United Kingdom posted a notice on-line announcing that COVID-19 had been downgraded from the status of High Consequence Infectious Disease (HCID).

This peculiar event has not gone entirely un-noticed but has never really been explained. Before this point the disease named in the document  as COVID-19 (rather than  identified as virus SARS-CoV-2) - was a “high consequence infectious disease”, while almost at the very instant our lives, and everyone’s,  were to be irrevocably pitched into turmoil with the denial of civil liberties and most basic human rights, untold economic destruction and chaos, it was no longer so designated.

If the disease was no longer “high consequence” there could be absolutely no reason for this high level and prolonged disruption, and yet it was at this precise moment that the inevitability of lockdown started to be promoted, only to be confirmed four days later. But according to the CMOs’ reckoning at no point in the past two and a quarter years, whatever actions they took to restrict our lives or coerce us to accept injections of novel products, has the disease been “high consequence”. 

This anomaly cannot I believe be stressed enough: my FOI request produced no new documents but the Department of Health and Social Care drew my attention to a Parliamentary answer by Jo Churchill on November 6,  2020 to Conservative MP John Redwood (submitted fully 5 and a half weeks before on September 28):

The four nations public health high consequence infectious disease (HCID) group made an interim recommendation in January 2020 to classify COVID-19 as an HCID, based on the information that was available during the very early stages of the outbreak.

Once more was known about COVID-19, United Kingdom public health bodies reviewed the available information against the HCID criteria and noted certain changes. These changes included the increase in information available about mortality rates, which are low overall amongst the general population; greater clinical awareness; and the availability of a specific and sensitive laboratory test for the virus.

COVID-19 has not been considered a HCID in the UK since 19 March 2020, but this reclassification has not affected the Government’s response to COVID-19, which remains a comprehensive national effort.

So, the junior minister, Jo Churchill, confirmed that decision was made with due consideration and not because of some expedience: this remained the case on November 6, 2020, and remains the case today because whatever the CMOs have said subsequently to the public, notably government Chief Medical Officer Sir Chris Whitty they have not updated this statement.

With this in mind let us go back and look at what was said in the statement of March 19, 2020 :it may be one of those occasions when British government documents are more revealing than most.

As of 19 March 2020, COVID-19 is no longer considered to be a high consequence infectious disease (HCID) in the UK. There are many diseases which can cause serious illness which are not classified as HCIDs.

The 4 nations public health HCID group made an interim recommendation in January 2020 to classify COVID-19 as an HCID. This was based on consideration of the UK HCID criteria about the virus and the disease with information available during the early stages of the outbreak. Now that more is known about COVID-19, the public health bodies in the UK have reviewed the most up to date information about COVID-19 against the UK HCID criteria. They have determined that several features have now changed; in particular, more information is available about mortality rates (low overall), and there is now greater clinical awareness and a specific and sensitive laboratory test, the availability of which continues to increase.

The Advisory Committee on Dangerous Pathogens (ACDP) is also of the opinion that COVID-19 should no longer be classified as an HCID.

Continue reading "The British Government, the World Health Organization and the Global Coup of 2020" »


Laugh or Cry: Researchers Catch Up With Autism Parents 25 Years Later

You don't sayDecades ago, a mentor taught me a saying, "Don't punish progress." It's pretty hard not to scream and shake my fists, "You SHOULD have listened to Andrew Wakefield instead of running him out of town on a rail."  Don't punish progress.  If young autism parents are still paying any attention to biomedical symptoms, causes and treatments, let's hope they read Safeminds' post from Monday.

May 15, 2022

A Bidirectional Relationship Exists Between Internalizing Behaviors and Gastrointestinal Issues

Researchers at the University of Missouri have recently published a study that suggests a connection between gastrointestinal problems, anxiety and social withdrawal for some children with autism. While conducting their study, the authors analyzed parent reports of gastrointestinal issues and internalizing behaviors of 621 minors with autism. The research team used path models in a structural equation modeling framework to further investigate their data. After examining the parental reports, the researchers believed the best-fitting model for this brain/gut phenomenon was a bidirectional model where internalizing behaviors (e.g., withdrawn and anxious behaviors) were associated with gastrointestinal issues (e.g., constipation, diarrhea, nausea and stomach pain). Sadly, this cycle then repeats, causing an endless loop of suffering for children experiencing both GI problems and internalizing behaviors. Co-author Brad Fergson expounds on his team’s work, stating, “Stress signals from the brain can alter the release of neurotransmitters like serotonin and norepinephrine in the gut, which control gastrointestinal motility, or the movement of stool through the intestines.” He adds, “Stress also impacts the balance of bacteria living in the gut, called the microbiota, which can alter gastrointestinal functioning. The gut then sends signals back to the brain, and that can, in turn, lead to feelings of anxiety, depression and social withdrawal. The cycle then repeats, so novel treatments addressing signals from both the brain and the gut may provide the most benefit for some kids with gastrointestinal disorders and autism.” Ferguson is currently involved in a clinical trial to assess how stress-reducing medication affects gastrointestinal problems. 

Original Article

Original Study Abstract


Why were Ingredients Associated with Clots Permitted in Covid Injections?: the British Regulator Stonewalls

June RaineWhy were ingredients known to be associated with clots permitted in Covid injections?: the British regulator stonewalls

By John Stone

This is a matter I first wrote about a year ago: as reports began to accumulate of clotting in recipients of the Oxford/AstraZeneca Covid injection a well-known biochemist pointed out to me that adenovirus component present in this product (as well as the Johnson & Johnson and Sputnik) had been a known risk for thrombocytopenia for two decades before these products were assembled at breakneck speed in February 2020. This presented a simpler issue than the mRNA products of Pfizer and Moderna where many of  the potential risks - though not all - were relatively speculative, since our governments had apparently authorised these products either knowing exactly what was likely to occur, or with alarming incompetence having failed to spot it. Back in April last year was the first time I asked had the MHRA (the British regulator) done due diligence.

Ultimately, in November 2021 I wrote to the CEO of the MHRA, June Raine, asking her point blank:

‘Can you explain why the MHRA permitted the use of adenovirus in Covid vaccines bearing in mind that it was known to be associated with clots?’

I did not hear back for a long while, and then on  22 February 2022 I received the following acknowledgement from someone signing himself “Peter”:

Our Reference: CSC 89455

Dear Mr John Stone,

Thank you for your email.

We have reviewed your enquiry and this has been passed on to our Licensing colleagues for further input.

It was an interesting day for this to occur because it was the day the Metropolitan Police announced that they would not be pursuing further criminal investigations into the Covid affair. I thanked “Peter” and waited a month and in place of an answer re-submitted my enquiry as a Freedom of Information request (which received an automatic acknowledgement). Then when the statutory 20 days for answering such a request had elapsed, earlier this week, I enquired again and received neither answer or acknowledgement. We have perhaps to conclude that we have reached the end of the line and the MHRA  cannot explain in any shape of form why they allowed so many people to be hurt, injured or even killed. 

The MHRA’s first assessed the connection between between the AZ product and thrombocytopenia as likely on 7 April 2021 but what they failed to acknowledge was that they were only geared to receiving a small fraction of reports as stated in a notice of 2018:

It is estimated that only 10% of serious reactions and between 2 and 4% of non-serious reactions are reported.

They knew therefore the risk to patients on which they continued to roll out the product was likely in the region of ten times worse than stated in their published reports, while fatalities were also reported at a much higher rate than for Pfizer and again might be ten times worse according to their own rule of thumb.

The issue of how far the British regulator which is an agency of UK Department of Health and Social Care and  is 100% funded by the industry, works for the public rather than the industry is more than ever moot, and this instance is complicated by the fact that the Secretary of State for Health and Social Care - at the time the controversial World Economic Forum advocate Matt Hancock  - was also a sponsor of the development of the product.

As long ago as 2005 the  House of Commons Health Committee remarked:

The Department of Health has for too long optimistically assumed that the interests of health and of the industry are as one. This may reflect the fact that the Department sponsors the industry as well as looking after health. The result is that the industry has been left to its own devices for too long.... The industry is by no means solely to blame for the difficulties we describe. The regulators and prescribers are also open to criticism. The regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), has failed to adequately scrutinise licensing data and its post-marketing surveillance is inadequate. The MHRA Chairman stated that trust was integral to effective regulation, but trust, while convenient, may mean that the regulatory process is not strict enough.  

And in 2020 I wrote in BMJ on-line:

Two years ago officers of the MHRA were defensive of their inability to detect the narcolepsy risk with the Pandemrix vaccine in the swine flu scare of 2009 nine years before…, despite heavy criticism..In 2020 they face a much more daunting task of assessing for licensure and monitoring a plethora COVID-19 vaccines, each of apparently novel design. I hope they are now able to give the public assurances that important lessons have been learned, and not just that they always get it right…

Yet nothing which has gone before seems to compare with the present recklessness over human life, and it is urgent government and regulator are held to account. There are many complex questions that the Covid episode has thrown up, but this one is as simple as it gets. Asked the most basic question they cannot, will not answer and manifestly there is something to hide.


Vax Hard With A Vengeance

C4B6EC4E-2C73-4DC7-9A6F-2F6A9DF07E60Actor Bruce Willis' daughter announced his retirement due to what reports indicate was a culmination of cognitive decline and now, aphasia. Like many, my first thought was "Oh no, I love Bruce Willis, how awful, I need to know more."

APHASIA: A language disorder that affects a person's ability to communicate.
It can occur suddenly after a stroke or head injury, or develop slowly from a growing brain tumor or disease. Aphasia affects a person's ability to express and understand written and spoken language. Once the underlying cause is treated, the main treatment for aphasia is speech therapy.

I remember the young, fast talking Bruce Willis of Moonlighting, decades ago. I hated to read of his plight. We of all people know about lack of ability to communicate. We know about regression into non-speaking. It's a horror.  I also went into territory most Americans don't even consider. Does the Covid vaccine have aphasia listed as an adverse effect?  I did a quick Brave search (No more Duck Duck Go or Google) the first hit was a case of a man who developed aphasia after his 2nd dose of an mRNA vaccine. https://pubmed.ncbi.nlm.nih.gov/34192245/

Then I went to OpenVaers.com and found 2,646 reports of Covid vaccine adverse events that include Aphasia.

We MUST be able to ask questions.  Consumers have a right to know that this side effect exists for this diagnosis they have never heard of.  We used to call that "informed" consent" before the Covid vaccine became a badge of honor or the lack of it became a of a mark of shame and societal exclusion.  Our President said he was losing patience with the unvaccinated. He said the unvaccinated faced a winter of “severe illness and death.” Harsh words. Dark admonitions. President Zelinsky hasn't been so blunt and cruel to his Ukrainian population.  But bombs don't carry the same global health weight as vaccination uptake.  Maybe Bruce Willis' terrible situation can help educate people not only on the definition of Aphasia, but one way it can be thrust upon you, beyond an unforeseen stroke or head injury out of the blue. No matter how Willis lost his way into dementia and lack of communication.

Correlation does not mean causation, as we have had jammed down our throats for decades.  Still, take note of the wording below regarding adverse effects, "though rare" and yet, "increasingly reported." 2, 646 increasingly reported to date. How can something be "rare" and "increasingly reported?"

Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine

https://pubmed.ncbi.nlm.nih.gov/34192245/

Abstract

Objectives: Though rare, neurological side effects of SARS-CoV-2 vaccinations are increasingly reported. Even if the first dosage goes uncomplicated, the second dose may be complicated by severe adverse reactions as in the following case.

Case report: A 52yo male developed sudden-onset reading difficulty and aphasia 7d after the second dose of an mRNA-based SARS-CoV-2 vaccine. He had a previous history of myocardial infarction, arterial hypertension, hyperlipidemia, and nephrolithiasis. Blood pressure was slightly elevated on admission. Blood tests revealed mildly elevated D-dimer, pre-diabetes and hyperuricemia. Cerebral magnetic resonance imaging revealed an intracerebral bleeding (ICB) in the left temporal lobe. Aphasia resolved almost completely within a few days. Blood pressure values were normal throughout hospitalisation. Whether there was a causal relation between the ICB and the vaccination remains speculative but cannot be definitively excluded.

Conclusions: A second dose of a SARS-CoV-2 vaccination may be followed by ICB. Though the pathophysiology of ICB remains unexplained a causal relation between ICB and the vaccination cannot be excluded. Risk factors for ICB should be carefully monitored in patients undergoing SARS-CoV-2 vaccination.

https://pubmed.ncbi.nlm.nih.gov/34192245/


Journal of Pediatrics Cardiac MRI Findings In Adolescents with Post-Covid mRNA Vaccine Myopericarditis

Broken heartMonday morning science, in the hope of preventing a family from Monday morning quarterbacking a decision.

Although symptoms were transient and most patients appeared to respond to treatment (soley with NSAIDS), we demonstrated persistence of abnormal findings on CMR at follow up in most patients, albeit with improvement in extent of LGE.

The presence of LGE is an indicator of cardiac injury and fibrosis and has been strongly associated with worse prognosis in patients with classical acute myocarditis.

###

Persistent Cardiac MRI Findings in a Cohort of Adolescents with post COVID-19 mRNA vaccine myopericarditis

Jenna Schauer, MD
Sujatha Buddhe, MD, MS
Avanti Gulhane, MD, DNB, FSCMR
Sathish Mallenahalli Chikkabyrappa, MD
Yuk Law, MD
Michael A. Portman, MD
Show all authors

Published:March 25, 2022DOI:https://doi.org/10.1016/j.jpeds.2022.03.032

Read the PDF here.

 


The Electric Kool Aid Autism Test

Electric kool aidThe world was simply and sheerly divided into 'the aware', those who had the experience of being vessels of the divine, and a great mass of 'the unaware', 'the unmusical', 'the unattuned.”

― Tom Wolfe, The Electric Kool-Aid Acid Test

When I was in high school, one book always caught my eye on the rotating rack of paperbacks. It was a well worn copy of Tom Wolf's The Electric Kool Aid Acid Test.  The cover and the flow of that title intrigued me, until I finally picked it up as a senior and read it. For those of us who have been BioMedHeads to help our kids with autism, there are few treatments that seem "far out"or "freaky" to us. Helminth therapy? Sure. Lupron? Worth a try. (Today Lupron is lauded for kids who may be trans, back 20 years ago the autism community was pilloried for ever considering lowering testosterone levels.)

Psilocybin has been in the news for its use in treating mental illness and below, SafeMinds talks about its potential for helping with autism. Psilocybin is found in fungi - yes, "Magic Mushrooms."  Shrooming might help our kids.  We've been on this fantastic voyage for a long time, wouldn't it be something if one thing made you larger and the other made you small, and the one's that mother gives you might help autism, depression and all?

Extensive Psilocybin Trial Shows Great Promise for Treating Serious Depression
Although Small Number Serious Adverse Events Were Reported

SafeMinds Shares has reported previously on psilocybin, a hallucinogenic/psychedelic substance that works by activating serotonin receptors in the prefrontal cortex, the area of the brain that affects mood, cognition, and perception. Early trials have shown that the psychedelic holds promise as an autism treatment since it supports the microbiome and normalizes serotonin levels.  Read more at SafeMinds.


ID 2020 Re-Visited: how Covid enabled the ID 2020 Alliance (Microsoft, Global Vaccine Alliance and Rockefeller Foundation) to take over our lives through the United Nations

Id2020by John Stone
 
I am returning to my article published exactly two years ago on Nov 1, 2019 in which I described some of the malevolent forces at play in global politics and predicted that the arrival of the new decade would be calamitous: I looked at the Global Health Security Agenda launched by Obama and then homed in on vaccine ID looking at the so-called ID 2020 Alliance (which brought together the vaccine industry cartel GAVI, with Microsoft and the Rockefeller Foundation (supposing these were ever entirely separate entities), and the European Commission roadmap - then just published - which  aimed amid zero publicity to have vaccine ID passports in place for the Union by 2022 (although there is no description of any mechanism that would enable this project). 
 
Of course, there was never any democratic stimulus for these initiatives: they started with corporate interests lobbying and infiltrating global and governmental institutions. According to a 2020 Wiki addition:
 
In May 2016, at the United Nations Headquarters in New York, the inaugural ID2020 summit brought together over 400 people to discuss how to provide digital identity to all, a defined Sustainable Development Goal including to 1.5bn people living without any form of recognized identification…Experts in blockchain and other cryptographic technology joined with representatives of technical standards bodies to identify how technology and other private sector expertise could achieve the goal…

There is admittedly at this stage no mention here of vaccine status as an integral part of this new ID and GAVI is not named as an original participant although it is named in the article as a participant in an ID 2020 project taking place in Bangladesh in 2019. Naturally UN Sustainable Development Goal is affiliated to Bill and Melinda Gates Foundation. Again according to Wiki:

“ID2020 is a public-private consortium in service of the United Nations 2030 Sustainable Development Goal of providing legal identity for all people, including the world's most vulnerable populations.

ID2020 has published a ten-point mission statement, which includes: "We believe that individuals must have control over their own digital identities, including how personal data is collected, used, and shared.”

Continue reading "ID 2020 Re-Visited: how Covid enabled the ID 2020 Alliance (Microsoft, Global Vaccine Alliance and Rockefeller Foundation) to take over our lives through the United Nations" »


Prime Minister Johnson lets the cat out of the bag: the vaccine does not stop you catching Covid or spreading it

Bill of goodsLast Friday while speaking on Sky News and urging members of the public to get their third Covid vaccination the British Prime Minister let go a remarkable admission:

“…the double vaccination provides a lot of protection against serious illness and death but it doesn’t protect you against catching the disease, and it doesn’t protect you against passing it on.”

This does not explain why the government are taking a wrecking ball to the care-home sector by insisting all its employees are vaccinated, and are placing a National Health Service - already on it knees - under similar threat. Our original Covid lockdown in March 2020 was touted by the government as “Six weeks to save the NHS”  our hospital staff and care home staff hailed as heroes - they were indeed, and many  or most will have by now immunity by exposure to the disease: none of which goes to explain why they are being hung out to dry or trampled under foot by an opportunist political class. Equally, the rationale behind vaccine passports is negated.

On Johnson’s admission there is no scientific basis on which these actions are protecting the public: so who or what are they for? In the words of the excellent former BBC historian/journalist, Neil Oliver, “We are not stupid”.

 

 

 


James Lyons-Weiler PhD Why Is Off-Label Off Limits for COVID-19

6B99BB63-4F7F-45E6-8EA7-C5867244C8CDNote: Can you think of any other serious diagnosis where ZERO mainstream treatments are approved? Where any effective treatment is jettisoned? Where doctors face a witch hunt and patients face ridicule and scorn for wanting to get better? Naaah, neither can we.

Who Are the World's Leading Authorities in COVID-19 Treatment? Public Health's "Medicine" is to go home and wait until you get sick (No Treatment Protocol). That is utterly unethical.

James Lyons-Weiler, PhD - 9/27/2021

At the onset of the COVID-19 pandemic, the mantra was “flatten the curve”. I had already done simulations showing that given the epidemiological parameters of COVID-19, its R0 in particular, that a multimodal approach would be necessary to bring the number of new cases down to a non-scary level. “A low buzz”, I called it, and one of the things I modeled was treatment.

I did this when we were told that the mortality rate among people with co-morbid conditions, like diabetes, was around 20%. It was also before the number of cases were polluted with data including false positives, and “presumed COVID” cases, in which doctors overrule negative tests, or give a diagnosis of COVID-19 without any confirming test. This was before CDC made the fatal error of conflating “PCR positive” with “COVID-19” and the likewise unscientific “Died with = Died From”. Given our intended success in moving a grand jury investigation forward in Oregon on CDC's failure to follow protocols for changing diagnostic and reporting criteria, there will almost certainly be a reckoning on that point.

By now, 9/27/2021, everyone has heard of Ivermectin, in large part due to Joe Rogan’s use of the FDA-approved drug, and of Hydroxychloroquine, in large part due to its support by Donald Trumps support of the FDA-approved drug and its subsequent politicization. The fact is, these treatments were found to be effective, as have others, by the first step in science - observation. In the US, off-label use is permitted for a potentially fatal condition when no standard of care exists. So people like Dr. Peter McCollough, and Dr. Pierre Kory, and Dr. Paul Marik, used observation to conclude that perhaps certain approaches to treatment might save lives, they acted. There was no standard of care; they recognized that there was no approved drug for treatment of COVID-19, so they appropriately reported their own, and others’ finding.   Read the extensive article here.


A Pilot Study on Covid and Autism: Prevalence, Clinical Presentation and Vaccine Side Effects

ScienceA Pilot Study on Covid and Autism: Prevalence, Clinical Presentation and Vaccine Side Effects

Abstract

Background: Several neurobiological mechanisms have been proposed to support the hypothesis of a higher COVID-19 risk in individuals with autism spectrum disorder (ASD). However, no real-world data are available on this population. Methods: We compared the period prevalence (March-May 2020) and symptom presentation of COVID-19 infections between a sample of individuals with severe ASD (n = 36) and the staff personnel (n = 35) of two specialized centers. Anti-SARS-Cov-2 antibody positivity was used as a proxy of infection. Additionally, we evaluated vaccine side effects in the same groups. Results: No significant difference was found between the prevalence of COVID-19 positivity between autistic participants and staff personnel. Levels of antibodies against the spike protein and the receptor binding domain were not significantly different between autistic and staff participants. The level of antibodies against the N-terminal domain were higher in autistic individuals. There was a significant difference between the prevalence of symptomatic COVID-19 in autistic participants (9.1%) compared to staff personnel (92.3%). The most frequent side effect among autistic participants was light fever.

Conclusions: The present study provides preliminary data on COVID-19 transmission and presentation in ASD. Our data do not support the hypothesis of a higher susceptibility and severity of COVID-19 in people with ASD.


Safeminds: Infant Gut Microbiome and Fear Response

Brain gut cartoon
https://cen.acs.org/biological-chemistry/microbiome/gut-might-modify-mind/97/i14

Note: Could the gut be the culprit behind the struggles of the young generation, riddled with anxiety, worry, and self-doubt? We know the role it plays in autistic behavior. And a certain doctor tried to ask hard questions a couple of decades ago, as you  may recall.....

###

Infant Gut Microbiome May Contribute to Fear Response Trajectory
Study Examines Microbiome Content for 1-Month and 1-Year Old Infants

The microbiome is the collection of trillions of microorganisms that colonize the digestive tract. Each person has a completely unique microbiome, made up of a network of microbiota originally determined by their DNA.

The microbiome is the collection of trillions of microorganisms that colonize the digestive tract. Each person has a completely unique microbiome, made up of a network of microbiota originally determined by their DNA. The microbiome develops rapidly during the first year of life. Previous research has linked human behaviors, including fear and anxiety, to the composition of the microbiome. It was due to these reasons that a research team from Michigan State University set out to study the emergence of fear responses in infants around 12-months old and examine if fear behavior is influenced by the development and composition of the microbiome. The Michigan State researchers theorized that there are critical windows in the development of the brain and nervous system in which variations in microbiome composition could impact infants’ fear behaviors and perhaps influence the physical structure of brain areas involved in generating fear. By recruiting a group of 34 infants, the study’s authors assessed microbiome contents and the volume of key brain regions at ages 1-month and 12-months. At the second assessment point, they also examined social and non-social types of fear behaviors in the infants. The study’s results indicated that the composition of the microbiome at 1-year “is significantly associated with increased fear behavior” and that differences in microbial colonization causes differences in fear. The researchers based these findings on a task designed to measure non-social fear. They also discovered that certain qualities of the 1-month microbiome were additionally associated with increased non-social fear at 1-year. Additionally, this study demonstrated a “suggestive” relation between contents of the infant microbiome and volumes of the amygdala and the prefrontal cortex. Despite finding associations between microbiome and variations between individual fear responses among the infants, the study’s authors say it is too early to label any specific microbiome contents as good or bad. This is mostly due to differences among individuals and also because some microbes may have positive and negative impacts in different contexts.


US COVID-19 Vaccines Proven to Cause More Harm than Good Based on Pivotal Clinical Trial Data Analyzed Using the Proper Scientific Endpoint, “All Cause Severe Morbidity” J. Bart Classen, MD*

New paper

FDA are expected to vote today to fully license the Pfizer vaccine while hiding the hideous fallout

https://www.scivisionpub.com/pdfs/us-covid19-vaccines-proven-to-cause-more-harm-than-good-based-on-pivotal-clinical-trial-data-analyzed-using-the-proper-scientific--1811.pdf


ABSTRACT

Three COVID-19 vaccines in the US have been released for sale by the FDA under Emergency Use Authorization (EUA) based on a clinical trial design employing a surrogate primary endpoint for health, severe infections with COVID-19. This clinical trial design has been proven dangerously misleading. Many fields of medicine, oncology for example, have abandoned the use of disease specific endpoints for the primary endpoint of pivotal clinical trials (cancer deaths for example) and have adopted “all cause mortality or morbidity” as the proper scientific endpoint of a clinical trial. Pivotal clinical trial data from the 3 marketed COVID-19 vaccines was reanalyzed using “all cause severe morbidity", a scientific measure of health, as the primary endpoint. “All cause severe morbidity” in the treatment group and control group was calculated by adding all severe events reported in the clinical trials. Severe events included both severe infections with COVID-19 and all other severe adverse events in the treatment arm and control arm respectively. This analysis gives reduction in severe COVID-19 infections the same weight as adverse events of equivalent severity. Results prove that none of the vaccines provide a health benefit and all pivotal trials show a statically significant increase in “all cause severe morbidity" in the vaccinated group compared to the placebo group. The Moderna immunized group suffered 3,042 more severe events than the control group (p=0.00001). The Pfizer data was grossly incomplete but data provided showed the vaccination group suffered 90 more severe events than the control group (p=0.000014), when only including “unsolicited” adverse events. The Janssen immunized group suffered 264 more severe events than the control group (p=0.00001). These findings contrast the manufacturers’ inappropriate surrogate endpoints: Janssen claims that their vaccine prevents 6 cases of severe COVD-19 requiring medical attention out of 19,630 immunized; Pfizer claims their vaccine prevents 8 cases of severe COVID-19 out of 21,720 immunized; Moderna claims its vaccine prevents 30 cases of severe COVID-19 out of 15,210 immunized. Based on this data it is all but a certainty that mass COVID-19 immunization is hurting the health of the population in general. Scientific principles dictate that the mass immunization with COVID-19 vaccines must be halted immediately because we face a looming vaccine induced public health catastrophe.


Nothing to see here! 60% of deaths are Covid vaccines on 30 year-old database

Nothing to see here42% of reports and 60% of fatal reports to VAERS (started in 1990) are for Covid products since December: fatal vaccine reports to Yellow Cards are more than 20,000% up on the year

By John Stone

This is a brief investigation into the public data as it stands in mid August 2021. I would add that the point is not that this is the highest quality data but that it is the only data there is - we are being deliberately deprived of real data through negligence at best, as the FDA confessed to the New York Times early on. They had not got the machinery running - or more likely  they had it running and were just were not telling us about it. And so we get back  to VAERS which was diagnosed in 2010 as being so deficient it was picking up less than 1% of events (at which point US government agencies evidently realised that they were on to a good thing and decided not to streamline it). So here are two relative measurements.

42% of all reports to VAERS from 1990 to August 13, 2021 are for Covid vaccines (595,662/1,409,664)

60% of all reports to VAERS “where patient died” from 1990 to August 13, 2021 are for Covid vaccines (13,068/21,936)

I am not saying that we should just multiply these figures simplistically by 100 but they are indicative that there is something drastically amiss.

Meanwhile, we have a different collection of data from the United Kingdom to August 11. Here we should bear in mind that the population of the UK is one fifth of the US and the licensing body, the MHRA, generally reckons that reports represent about 10% of cases.

To date there have been 347,032 Yellow Cards, 1,151,768 Adverse Events, 1,596 Fatal 

This breaks down as follows:

Pfizer 36.6m doses 104,446 (1 Yellow Card in 350) 293,779 Adverse Events (2.8 per card) 501 Fatalites (1 in 73,054)

Astra Zeneca 48.6m doses 228,239 Yellow Cards  (1 in 213) 813,622 Adverse Events (3.6 per card) 1,053 Fatalities (1 in 46,154)

Moderna 2m doses 13,325 Yellow Cards (1 in 150) 41,274 Adverse Events (3 per card) 14 Fatalities (1 in 142,857)

Brand unspecified 1,022  Yellow Cards 3,093 Adverse Events 28 Fatalities

The fact that three brands have such distinct adverse event profiles argues strongly against this being background noise, however there are overwhelming reasons why most reports would never get made: people will not report because they don’t know to, because they don’t know how to, because the ethos is overwhelmingly hostile and they think it is the wrong thing to do or they are scared, or because they are too sick or even dead. By comparison the average number of vaccine reports for the previous ten years was 3,039 with 8 fatalities: 200 times the fatalities and we are not a year in: off the scale and the world is run by madmen.


Subscribe to Professor Exley's Aluminium Research Group Site

AluminumOver the last few years, and certainly since the COVID lockdown in 2020, we've discussed how we will communicate if and when we are "shut down" whether by social media or web platforms, or even our employers. When AofA was launched 14 years ago, one of our main focuses was on mercury. Since that time, aluminum has become a topic of grave concern, due in large part to the work of Professor Christopher Exley, whose tenure at Keele University in the UK will be coming to a close at the end of August.

Professor Exley is creating a website where you can continue to follow and support his important work. We invite you to click in and SUBSCRIBE to updates.

Welcome to the Aluminium Research Group

Are you interested in keeping in touch with our research? If so, please feel free to subscribe to our mailing list here, thank you: Subscribe

The Birchall Centre

Welcome to the website of the Aluminium Research Group. The group was previously based in The Birchall Centre, Keele University from 1992 to 2021. We are currently looking for a new home. In the meantime we have set up this website to keep as many as possible informed about our research and research activities.

Our Research

The Unit started off with three general themes, of which our group focus is Aluminium and Silicon in Biology. The group is led by Professor Christopher Exley, FRSB and the current research themes within the group are varied, including metals and amyloids; biosilicification in plant species; human exposure to Aluminium, whether intentional (e.g. in antiperspirants or adjuvants) or unintentional; and hydroxyaluminosilicates.

 


Autism Tsunami: the Impact of Rising Prevalence on the Societal Cost of Autism in the United States

Breaking newsCongratulations to authors Mark Blaxill (Age of Autism Editor-At-Large), Toby Rogers and Cynthia Nevison.

Blaxill, M., Rogers, T. & Nevison, C. Autism Tsunami: the Impact of Rising Prevalence on the Societal Cost of Autism in the United States. J Autism Dev Disord (2021). https://doi.org/10.1007/s10803-021-05120-7

Abstract

The cost of ASD in the U.S. is estimated using a forecast model that for the first time accounts for the true historical increase in ASD. Model inputs include ASD prevalence, census population projections, six cost categories, ten age brackets, inflation projections, and three future prevalence scenarios. Future ASD costs increase dramatically: total base-case costs of $223 (175–271) billion/year are estimated in 2020; $589 billion/year in 2030, $1.36 trillion/year in 2040, and $5.54 (4.29–6.78) trillion/year by 2060, with substantial potential savings through ASD prevention. Rising prevalence, the shift from child to adult-dominated costs, the transfer of costs from parents onto government, and the soaring total costs raise pressing policy questions and demand an urgent focus on prevention strategies. Read here: https://doi.org/10.1007/s10803-021-05120-7

The Journal of Autism and Developmental Disorders is the leading peer-reviewed, scholarly periodical focusing on all aspects of autism spectrum disorders and related developmental disabilities.

Continue reading "Autism Tsunami: the Impact of Rising Prevalence on the Societal Cost of Autism in the United States" »


Safeminds Reports Contradicting Study on Maternal Smoking and Autism

Doctors smokeThank you to Safeminds for updating the community with new science. Science is rarely settled.

New Study Contradicts Last Month’s Study Showing an Association

Citing that research on in utero exposure to maternal environmental tobacco smoke (ETS) or active maternal smoking and the development of autism spectrum disorder (ASD) has been inconsistent, researchers from the California Department of Public Health set out to examine in utero cotinine concentrations as a tobacco exposure measurement. The results of their new study was recently published in Autism Research, the official journal of the International Society of Autism Research (INSAR). In order to conduct this research, the study’s authors measured cotinine levels in blood samples of women in their second trimesters.  A total of 498 ASD cases and 499 controls born in California during 2011-2012 were accessed for this investigation. The research team also obtained self-reported maternal cigarette smoking habits during and immediately prior to pregnancy as well as other pertinent information from birth records.  After running the data on the mother’s cotinine concentrations, the researchers found no association between in utero exposure to tobacco smoke from maternal ETS exposure or from active smoking and ASD. This finding contradicts a study from a few weeks ago which reported that heavy smoking during pregnancy was linked to autism in offspring. Last month’s study came to their conclusion by connecting California birth records to cases of autism maintained by the California Department of Developmental Services. However, this new study is the first to measure cotinine in mother’s blood during pregnancy and then study the chemical’s association with the development of autism in offspring. The March of Dimes, an organization dedicated to fighting for the health of all pregnant mothers and babies, produces a list of dozens of health risks for infants born to mothers who smoke. Interestingly, autism is not included on their list which reinforces the conclusion of this new study and also adds more evidence that maternal smoking during pregnancy is not fueling the autism epidemic.

Study Abstract


The Aluminium Content of Infant Vaccines Is Akin To A Lottery

The Lottery cover
Shirley Jackson's story exposed the willingness of townfolk to harm others to protect themselves as if a ritual.

Below is a link to Professor Chris Exley et al research. Exley is a Professor in Bioinorganic Chemistry in the Aluminium and Silicon Research Group at The Birchall Centre, Lennard-Jones Laboratories, at the UKs'sKeele University and a preeminent expert in aluminum toxicity.

While the world revolves around COVID as if it is the sun, moon and stars, there is a universe of danger that honorable scientists are still studying. Thank God. Professor Exley, of course, has been censored and punished for his work. 

Vaccine manufacturers are not held to any gold standard. You can have more faith in the number of crisps in a bag than the toxic metals in vaccines mandated for children.

###

The measurement and full statistical analysis including Bayesian methods of the aluminium content of infant vaccines

Abstract

Background

Aluminium salts are the most common adjuvants in infant vaccines. The aluminium content of a vaccine is provided by the manufacturer and is indicated on the patient information leaflet. There is no independent verification, for example by the European Medicines Agency, of the aluminium content of infant vaccines.

Methods

We have measured the aluminium content of thirteen infant vaccines using microwave-assisted acid and peroxide digestion followed by transversely heated graphite furnace atomic absorption spectrometry. Our data are compared with manufacturer’s data using full statistical analyses including Bayesian methods.

Results

We found that only three vaccines contained the amount of aluminium indicated by the manufacturer. Six vaccines contained a statistically significant (P < 0.05) greater quantity while four vaccines contained a statistically significant (P < 0.05) lower quantity. The range of content for any single vaccine varied considerably, for example, from 0.172 to 0.602 mg/vaccine for Havrix.

Conclusions

The data have raised specific questions about the significance of the aluminium content of vaccines and identified areas of extremely limited information. Since aluminium is a known toxin in humans and specifically a neurotoxin, its content in vaccines should be accurate and independently monitored to ensure both efficacy and safety.


Deregulating GM: Obscene Farce of the Modern British State

image from upload.wikimedia.orgBy John Stone
 
This is a succinct response to the British government consultation on the future of GMO technology taking place amid zero publicity and about to close (last day for submissions Wednesday). Note also the valuable introduction at Alliance for Natural Health.
 
Response to consultation ‘The regulation of genetic technologies’

This document is couched in up-side down language which some might term Orwellian:

1) It is actually about the deregulation of genetic technologies

2) It represents this as a “green” policy when it is patently an opportunistic attack by an industrial lobby on our natural environment, and upon bio-diversity. It could not be more anti-green in any way that could normally or traditionally be understood

3) Previous moves of this kind globally have left small and medium landholders at the mercy of grasping, unscrupulous manufacturers

4) If part of the argument is that the putative advances could also be achieved without GM technology, why do we need GM at all? This is not a credible explanation for changing the law

5) If GM is deregulated the only people the manufacturers will be answerable to is their shareholders, so how is the public interest represented?

6) I tried taking the survey but found it full of leading questions

It is shocking that this matter is not being raised in an openly democratic manner. While the British public have always rejected GM produce to the extent that it is presently unsaleable in our country, deregulating it was never conspicuously brought up as a reason for leaving the European Union at the time of Referendum in 2016 or at the December 2019 General Election: the only time I recall this project being mentioned was the Prime Minister’s speech on entering Downing Street in July 2019. This is a radical departure for the UK but the public are being cynically kept out of the picture - although there is the present consultation you will not read or hear about it in the mainstream media. One can deduce that the reason for this is that if it was adequately reported it would be overwhelmingly unpopular.

The slogan ‘Building back greener’ used in the document derives from the World Economic Forum who are also putting it out that in ten years-time no one but a tiny global elite will own anything but “will be happy”. If the government is dancing to the tune of the Great Reset perhaps it should tell the public who elected it where it is heading because no one could have imagined little more than a year ago what they were voting for. So much for Margaret Thatcher's “property-owning democracy” recently reiterated by the Prime Minister while apparently hooked into an alternative, techno-feudalist, ideology. What now are we to believe either about the environment, safe food, property or democracy?

John Stone, UK Editor, Age of Autism


Science Has Never Been Settled

Question authorityI saw this video on Facebook yesterday, and could not help but draw a bead from ancient Rome and modern Western medicine. Medicine has always fought new science when it challenged their dearly held beliefs.  Few groups know this better than the biomedical and vaccine injury autism community.  Vesalius had to combat some 1300 years of Galen of Pergamon's work, which was considered the gold standard of scientific belief. But the video is just 5 minutes long.

###

From TedEd: Learn about the Greek physician and philosopher Galen of Pergamon, whose experiments and discoveries changed medicine. -- In the 16th century, an anatomist named Andreas Vesalius made a shocking discovery: the most famous human anatomy texts in the world were wrong. While Vesalius knew he was right, announcing the errors would mean challenging Galen of Pergamon. Who was this towering figure? And why was he still revered and feared 1,300 years later? Ramon Glazov profiles the most renowned physician in medical history. Lesson by Ramon Glazov, directed by Anton Bogaty.


Dr. James Lyons-Weiler: Public Health Has a Plan B

Plan BJames Lyons-Weiler, PhD

1/5/2021

AS ONE WHO UNDERSTANDS complex dynamic systems, and is admittedly puzzled by the death of bioethics in the United States over the last decade, and as one with first-hand direct experience witnessing the pressures placed on biomedical researchers that place bottom-line concerns over health outcomes, in honor of those individuals in medicine and public health who have stayed the course and not sold out, I am pleased to propose a new approach to Public Health in one of my two latest peer-reviewed publications. It is a blueprint for reason-based, reality-based public health and a return to the public good model of medical practice.

Due to suppression, please share this across diverse social media platforms and by email. Take it to those who say they represent you. We must succeed.

Lyons-Weiler, J. 2020. Plan B Public Health Infrastructure and Operations
Oversight Reform for America. Intl J Vacc Theor, Pract, Research 1(2):283-294.

Click here to read Lyons-Weiler, J. 2020. Plan B Public Health Infrastructure and Operations Oversight Reform for America. Intl J Vacc Theor, Pract, Research 1(2):283-294.


UK Faces Food Shortages As A Result Of Conflicted Government Science

 image from www.gavi.orgBy John Stone

European countries have been shutting down their borders with the United Kingdom following advice that it harbours a 70% more contagious version of the Covid virus, which has already led to the new Tier 4 lockdown arrangements in Southern England and the effective cancellation of Christmas. Whether the mutation is actually more contagious is a matter for dispute between two Oxford professors. The case that the “strain” is more contagious has been hypothesised by the Nervtag advisory committee led by Prof Peter Horby. According to the Daily Mail Prof Horby, who is Professor of Emerging Infectious Diseases at the Centre for Tropical Medicine and Global Health, said the figure of 70 per cent was based on 'converging data'.

“He said: 'This is including, but not limited to, the rate of change in the frequency of detection of the variant (the growth rate) and the correlation between R values and the frequency of detection of the new variant.'”

This, however, is disputed by Prof Carl Heneghan of the Centre for Evidence Based Medicine. He told the Mail:

'I've been doing this job for 25 years and I can tell you can't establish a quantifiable number in such a short time frame.' 

He added 'every expert is saying it's too early to draw such an inference'.

Professor Heneghan said there was no doubt this time of the year, the 'height of the viral season', was a difficult time for the NHS. But he said failure to put out the basis of the figures was undermining public trust.

But while the mutation is already circulating in other European countries it has led to them shutting down food supplies to the UK coincidentally or not on the very verge of Brexit. Prof Horby had previously been embroiled in controversy earlier this year over the Hydroxychloroquine trial in which inappropriately high quantities of HCQ  were given to Covid patients already in a serious condition (the trial was funded by the Wellcome Trust and the Bill and Melinda Gates Foundation). Also on the Nervtag Committee is Prof Ferguson of Imperial College whose controversial modelling led to the UK’s first lockdown in the spring. Ferguson was forced to resign from the more prominent SAGE committee after breaking lockdown rules pursuing a romantic liaison, but not apparently from Nervtag. Ferguson’s Vaccine Impact Modelling Consortium at Imperial College is also funded by the Bill and Melinda Gates Foundation as well as the global vaccine alliance, GAVI. Ferguson's group was said to have received $185 million from the Bill and Melinda Gate Foundation between 2006 and 2018.

Converging data or converging interest?


iPAK Presents Vax Unvaxxed Study with Zero ADHD

Science post imageLyons-Weiler, J.; Thomas, P. Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses Along the Axis of Vaccination. Int. J. Environ. Res. Public Health 202017, 8674. 

Open Access (No Firewall)

Abstract: https://www.mdpi.com/1660-4601/17/22/8674
HTML Version: https://www.mdpi.com/1660-4601/17/22/8674/htm
PDF Version: https://www.mdpi.com/1660-4601/17/22/8674/pdf

Link to this page: http://ipaknowledge.org/ipak-vaxxed-v-unvaxxed-study.php

We are now moving on to Phase 2 of our study, in which they will focus on the comparison of health outcomes associated with live vs. non-live vaccines, aluminum-containing vaccines vs. non-aluminum containing vaccines, as well as studying the impact of individual vaccines on specific health outcome risks.  Become an IPAK Science Hero and make the world a safer place for our children through objective science.

In this study of over 3300 patients, we found ZERO ADHD in the unvaccinated group (N=561). We found that using billed office visits was a more powerful test than the weaker odds ratio of incidence. Even after blocking for healthcare exposure/age, family history of autoimmunity, and gender, the associations of many bad health outcomes were robust. Anemia was especially prominent in the vaccinated. Here is our announcement.

The IPAK team and Dr. Paul Thomas have published the first results from the Vaxxed vs. Unvaxxed study in the study "Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses Along the Axis of Vaccination".

Continue reading "iPAK Presents Vax Unvaxxed Study with Zero ADHD" »


Adjuvants: The BBC's Fairy Dust Future

image from external-content.duckduckgo.comby John Stone

Two days ago I received at breakfast a magazine article from an outfit called BBC Future entitled Immune Respose: The Strange Ingredients Found in Vaccines by Zaria Gorvett (pictured left).That the BBC should supply such a bland and poorly informed article for the popular market is no surprise, but nevertheless my annoyance did rise at her account of the DPT affair, and I wrote to her:

Dear Ms Gorvett,

Re: Your article “Immune Response” this morning

Despite the opprobrium heaped on John Wilson the government discreetly paid out on 600 DPT cases within three years of the vaccine damage payment act of 1979. In a letter last year to BMJ (which I append)  I also pointed out the paper by Mogensen which found that mortality in DPT vaccinated infants in Guinea-Bissau (1981) was 5 times vaccinated. This is not a small matter.

I also point out that size comparison makes no sense when talking (about)  an active ingredient of a product and I forward the link to the recent article by Prof Exley “An aluminium adjuvant in a vaccine is an acute exposure to aluminium”.

It is not correct to say that there is no evidence when there is evidence and I think you ought to reconsider.

Yours sincerely,

 John Stone, UK Editor, Age of Autism

The Benefits of DPT

(BMJ Rapid Response)

Mara Kardas-Nelson [1] should also note that as result of DPT controversy and the UK Vaccine Damage Payment Act of 1979 there were 600 payments in the period 1978-81 (1978/9: 36, 1979/80: 317, 1980/1: 256) [2,3]. The rhetoric behind the legislation was that injuries were rare but this was not borne out by the record [2,3]. The act enabled the government to retrieve the reputation of the programme amid adverse publicity by acknowledging the principle of harm but no one knew how many awards there had actually been - and initially there were a lot. This would also not take account of any deaths.

According to Mogensen et al, the introduction of DPT to Guinea-Bissau in 1981 was associated with a 5 fold increase in the rate of death [4]:

"Among 3–5-month-old children, having received DTP (±OPV) was associated with a mortality hazard ratio (HR) of 5.00 (95% CI 1.53–16.3) compared with not-yet-DTP-vaccinated children. Differences in background factors did not explain the effect. The negative effect was particularly strong for children who had received DTP-only and no OPV (HR = 10.0 (2.61–38.6)). All-cause infant mortality after 3 months of age increased after the introduction of these vaccines (HR = 2.12 (1.07–4.19))."

[1] Kardas- Nelson, 'Despite high rates of vaccination, pertussis cases are on the rise. Is a new vaccination strategy needed?', BMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l4460 (Published 09 July 2019)

[2] Gareth Millward, 'A Disability Act? The Vaccine Damage Payments Act 1979 and the British Government’s Response to the Pertussis Vaccine Scare', Social History of Medicine, Volume 30, Issue 2, May 2017, Pages 429–447, https://doi.org/10.1093/shm/hkv140

[3] 'Annex A - Vaccine Damage Payments claims received and award statistics', https://www.whatdotheyknow.com/request/242813/response/599844/attach/3/A...

[4] Mogensen et al, 'The Introduction of Diphtheria-Tetanus-Pertussis and Oral Polio Vaccine Among Young Infants in an Urban African Community: A Natural Experiment', Ebiomedicine March 2017, https://www.ebiomedicine.com/article/S2352-3964(17)30046-4/abstract

I forgot to mention that the old DPT contained 50 micrograms of life-enhancing ethyl mercury but not receiving  an answer I decided to forward it to her editor Amanda Ruggeri (below), who describes herself on her website as  “Journalist, Photographer, Traveler,  Historian,  Adventurer”, and obviously a very exciting person. She also has not replied. image from external-content.duckduckgo.com

What I did not know at the time that I wrote to Zaria was that before writing her amusing vaccine fairy story she had interviewed Prof Exley at length on the phone. Yesterday, he wrote to her furiously:

Dear Zaria,

This not about whether one 'likes' something or not. It is about your integrity as a journalist.

You contacted me by email to ask my advice. I was happy to help and even gave you my home telephone number since you wished to talk to me personally and not simply correspond by email.

We talked for about forty minutes. I shared with you a great deal of scientific, published, information on our expertise in aluminium adjuvants used in vaccines. I made sure that you had access to all the primary published research that we talked about. I also gave you some background on adjuvants generally. You gave the impression of both being very interested in the information I gave you and also of being grateful for my time and expertise. Afterall we are, arguably, the world's leading group researching the efficacy and safety of aluminium adjuvants used in vaccines.

When we finished our conversation, you promised to send me a link to your article. You did not do this and reading your article, I can understand why.

Not only did you not mention my contribution to your article once but when opportunities arose you chose to write what can only be described as blatant lies.

For example, even though you knew that what you had written was untrue you still wrote;

There is as little as 0.2mg of aluminium in a typical vaccine dose, which is equivalent to less than the weight of a single poppy seed. There is no evidence that any of the adjuvants currently in use lead to side-effects.

Apart from being factually incorrect the comparison with a poppy seed is absurd at best.

What happened to your editor's mantra concerning BBC Future;

We believe in truth, facts, and science. We take the time to think. And we don't accept — we ask why.

I told you everything you needed to know about how much aluminium is used in vaccines. I even shared with you some of our new research in this field about to be published in the BMJ. I pointed out to you that there are serious adverse events caused by aluminium adjuvants and I also informed you as to where you could find this information, no lesser document than the patient information leaflet provided with every vaccine.

Your writing about DPT is completely false and while we did not discuss this you could have checked this information with me at any time. You clearly chose not to check your information.

I told you the story of Glenny and the 'discovery' of aluminium adjuvants.

I also made sure that you understood which aluminium salts were used as aluminium adjuvants. Instead you wrote lies again about this;

To this day, the aluminium in vaccines is always in the form of salts. These include aluminium hydroxide (commonly used as an antacid to relieve indigestion and heartburn), aluminium phosphate (often used in dental cement) and potassium aluminium sulphate, which is sometimes found in baking powder.

You decided instead to write complete scientific nonsense in your descriptions of aluminium salts used in vaccines, why is beyond me when you had access to the correct information. What were you trying to do, make the aluminium salts sound benign by comparing them wrongly to household products?

I told you that the main reason why aluminium adjuvants are effective is because they are toxic at the vaccine injection site. I spoke to you at length about this and I pointed you towards the relevant peer reviewed published scientific literature. Your reference to uric acid at this point did not come from me and has no relevance.

This article is very shoddy journalism. It seems to have been primarily informed by a Chinese scientist working on vaccines in China. As the world's leading researcher on aluminium, I have no knowledge of this scientist only that they have no expertise in aluminium adjuvants. Why you chose to only follow their advice is insulting.

If you and your editors do truly 'believe in truth, facts, and science', then I would expect a right of reply to this inaccurate and scientifically inept article. To not do so would suggest that the written lies therein have an alternative agenda.

Yours sincerely

image from i.ytimg.com

 

 

 

 

 

Professor Christopher Exley PhD FRSB

So far, at the time of writing, Prof Exley assures me he has heard neither from Zaria Gorvett or her editor Amanda Ruggeri (which is I suppose what you would expect from the modern BBC). Perhaps as their next assignment these two geniuses can set themselves to working out why Autism Spectrum Disorders have reached 7% in Belfast schools (I have had an identical figure just quoted me by personal communication for the first year in-take of a Welsh comprehensive school). All brought to you by the BBC’s responsible journalism.

Post Script

Prof Exley has now received a succession of letters from the BBC which does not make their position any more satisfactory:

Dear Professor Exley,

Thank you very much for speaking with me the other day. I am sorry that you do not like the article. I have cc'd my editors.

Best regards,

Zaria  

*

Dear Prof. Exley,

Thank you for raising your concerns with BBC Future. We’re sorry that you feel your time in the interview was wasted; we seek information from a wide range of sources, and there is no guarantee when we do interviews that any given interviewee will be quoted or mentioned in a piece.

We’ve gone through the claims you make below and remain confident in the accuracy of our reporting. Thank you again for your time.

Best,

Amanda Ruggeri

*

Dear Professor Exley,

I’m the Editorial Director for the BBC’s international news and features output.    Amanda has passed your complaint onto me.

Let me echo Amanda’s apology for the fact that you feel your time was wasted.    We speak to a lot of people in the course of our research and are grateful to anyone who gives up their time. 

The article was amended on Thursday to clarify two points:

The weight of evidence is that adjuvants do not lead to serious side-effects.

And we added detail about the link between the pertussis vaccine and encephalopathy and corrected the statement that the vaccine had been administered for decades without incident.

Best wishes,

Mary

Mary Wilkinson, Head of Editorial Content,  BBC Global News  Ltd

Of course, no one actually says sorry for their actions, and all three are guilty of deliberately misleading the public by failing to report that they had consulted him and received  information of substance (existing in the form of peer reviewed studies in respected journals)  which stood in contradiction to the claims of the published article. If they were professionally fearful of the consequences of publishing this information then it might have been better not to publish at all. Plainly none of them have the expertise to discard Prof Exley's evidence and there is no explanation of why they chose to do this except expedience.


Simon & Schuster Presents "Imagine You Are An Aluminum Atom" by Professor Christopher Exley

Imagine-you-are-an-aluminum-atom-9781510762534_lgWe are so pleased to see that publishing giant Simon & Schuster has announced Christopher Exley's book "Imagine You Are An Aluminum Atom!"  Please click here and pre-order a copy from your favorite bookseller.  If you use Amazon, consider marking Age of Autism as your SMILE charity. Thank you.

From S&S:

Join "Mr. Aluminum," a scientist who has made the study of aluminum his life's work, on a journey of discovery, reflection, and the science of aluminum.

Professor Christopher Exley is a firm believer that science is only useful when it is properly communicated. Scientific papers are difficult vehicles for the wider communication of science and thus he has always endeavored to tell the story of his scientific research as widely as possible through myriad blogs, presentations, and interviews. Through a series of easy-reading entries written for non-scientists, Exley will educate readers about his lifelong scientific passion: aluminum. In scientific circles, aluminum—in relation to human health specifically—has gone the way of the dinosaurs (though, unlike dinosaurs, there has not yet been a popular revival!). Yet aluminum is also the greatest untold story of science.

But why do we all need to know a little bit more about aluminum? Do we need a self-help guide for living in what Exley has coined "The Aluminum Age"? What is it about aluminum that makes it different? What about iron, copper, or any of the so-called "heavy metals," like mercury, cadmium, or lead? Why must we pay particular attention to aluminum? Because its bio-geochemistry, its natural history, raises two red flags immediately and simultaneously.

These two danger signals are easily missed by all of us and easily dismissed by those whose interests are conflicted by aluminum’s omnipresence in human life and consequently, are purposely blind to its danger signals. First, aluminum, in all of its myriad forms, is super abundant; it is the third most abundant element (after oxygen and silicon) of the Earth’s crust. Second, aluminum is super reactive; it is both chemically and biologically reactive. However, these two red flags identify a paradox, as the abundant and biologically reactive aluminum has no biological function either in any organism today nor in any extinct biota from the evolutionary past. This means in practical terms that when we encounter aluminum in our everyday lives, our bodies only see aluminum as an impostor, something foreign, and something for which we have not been prepared through biochemical evolution. This in turn means that all of our encounters with aluminium are adventitious, random, and chaotic. And potentially dangerous.

Imagine You Are An Aluminum Atom: Discussions With "Mr. Aluminum" examines the science of aluminum and human health and makes them understandable to all. Within the science you will find personal recollections of events, as well as opinions and reflections upon how the politics of aluminum have influenced and interfered with doing and reporting the science. It is at once both a personal recollection of Exley's life in aluminum research and a guide on the dangers of the constant exposure to aluminum we as humans face during this "Aluminum Age." It will inform, it will provide the means to question the science, and it will, if the reader is prepared to participate, answer those frequently asked questions on aluminum and human health.


Fake Placebo Meningitis Vaccine May Have Killed Healthy 28 Year Old Brazilian Covid Vaccine Volunteer

That's the headline Reuters should have written, instead of AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continue.

Candy syringe pensIf you ask anyone with middle school grasp of science what is a "placebo," they will likely say, "a sugar pill."  A placebo has always meant an inert, benign substitute for the drug being tested.  How many Earthlings understand that with this Covid vaccine, the placebo is another vaccine? And in this case, it may well have killed a healthy, altruistic 28 year young man. Our sincere condolences to his grieving family. He volunteered to help others.   And what of every parent whose child needs a meningitis vaccine for school? Are they to feel comforted?

noun
noun: placebo; plural noun: placebos

a harmless pill, medicine, or procedure prescribed more for the psychological benefit to the patient than for any physiological effect.
"his Aunt Beatrice had been kept alive on sympathy and placebos for thirty years"
a substance that has no therapeutic effect, used as a control in testing new drugs.
a measure designed merely to calm or please someone.
"pacified by the placebos of the previous year, they claimed a moral victory"

###

SAO PAULO/FRANKFURT (Reuters) - Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.Oxford confirmed the plan to keep testing, saying in a statement that after careful assessment “there have been no concerns about safety of the clinical trial.”

AstraZeneca declined to comment immediately.

A source familiar with the matter told Reuters the trial would have been suspended if the volunteer who died had received the COVID-19 vaccine, suggesting the person was part of the control group that was given a meningitis jab.  Read more here.


Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer’s Disease and Related Neurological Disorders

AluminumAuthors: Mold, Matthew Johna; * | O’Farrell, Adamb | Morris, Benjaminb | Exley, Christophera; *

Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer’s Disease and Related Neurological Disorders

Abstract

Background:

Protein misfolding disorders are frequently implicated in neurodegenerative conditions. Familial Alzheimer’s disease (fAD) is an early-onset and aggressive form of Alzheimer’s disease (AD), driven through autosomal dominant mutations in genes encoding the amyloid precursor protein and presenilins 1 and 2. The incidence of epilepsy is higher in AD patients with shared neuropathological hallmarks in both disease states, including the formation of neurofibrillary tangles. Similarly, in Parkinson’s disease, dementia onset is known to follow neurofibrillary tangle deposition.

Objective:

Human exposure to aluminum has been linked to the etiology of neurodegenerative conditions and recent studies have demonstrated a high level of co-localization between amyloid-β and aluminum in fAD. In contrast, in a donor exposed to high levels of aluminum later developing late-onset epilepsy, aluminum and neurofibrillary tangles were found to deposit independently. Herein, we sought to identify aluminum and neurofibrillary tangles in fAD, Parkinson’s disease, and epilepsy donors.

Methods:

Aluminum-specific fluorescence microscopy was used to identify aluminum in neurofibrillary tangles in human brain tissue.

Results:

Continue reading "Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer’s Disease and Related Neurological Disorders " »


“The Largest Unethical Medical Experiment in Human History”

EMF warningNote: Many of our readers have taken steps to thwart wireless in their homes. However, with COVID school and work restrictions, most all of us are being forced to use wireless devices several hours every single day. It's a Zoom/Google Classroom world. There's no avoiding EMF. Dr. Kostoff,  a valued AofA reader and commenter, has written an detailed monograph that we share today. I looked up the term "monograph, and learned that it means "a detailed written study of a single specialized subject or an aspect of it." Mono - one. Graph - writing.

THE LARGEST UNETHICAL MEDICAL EXPERIMENT IN HUMAN HISTORY

Ronald N. Kostoff, Ph.D.Research Affiliate, School of Public Policy, Georgia Institute of Technology

KEYWORDS Unethical Research; Electromagnetic Fields; Wireless Radiation; Radio frequency Radiation; RF; Non-Ionizing Radiation; Mobile Networking Technology; 5G; Adverse Health Effects

ABSTRACT

This monograph describes the largest unethical medical experiment in human history: the implementation and operation of non-ionizing non-visible EMF radiation (hereafter called wireless radiation) infrastructure for communications, surveillance, weaponry, and other applications. It is unethical because it violates the key ethical medical experiment requirement for “informed consent” by the overwhelming majority of the participants.

The monograph provides background on unethical medical research/experimentation, and frames the implementation of wireless radiation within that context. The monograph then identifies a wide spectrum of adverse effects of wireless radiation as reported in the premier biomedical literature for over seven decades. Even though many of these reported adverse effects are extremely severe, the true extent of their severity has been grossly underestimated. Most of the reported laboratory experiments that produced these effects are not reflective of the real-life environment in which wireless radiation operates.

Many experiments do not include pulsing and modulation of the carrier signal, and most do not account for synergistic effects of other toxic stimuli acting in concert with the wireless radiation. These two additions greatly exacerbate the severity of the adverse effects from wireless radiation, and their neglect in current (and past) experimentation results in substantial under-estimation of the breadth and severity of adverse effects to be expected in a real-life situation. This lack of credible safety testing, combined with depriving the public of the opportunity to provide informed consent, contextualizes the wireless radiation infrastructure operation as an unethical medical experiment.  Continue reading here.


Aluminum is a Secret Sauce!

Burger foilSuch a clever headline  and a WHOPPER of an obfuscation from National Pharma Radio, aka NPR. In the article they jauntily refer to a substance called "alum...."  The author might want to check in on the work of Chris Exley in the UK. His latest? The role of aluminum adjuvants in vaccines raises issues that deserve independent, rigorous and honest science

From NPR:

The Special Sauce That Makes Some Vaccines Work

There are many approaches to making a vaccine against COVID-19. Some use genetic material from the coronavirus, some use synthetic proteins that mimic viral proteins and some use disabled versions of the virus itself.

But before any of these approaches can generate the antibodies to the coronavirus that scientists say are essential to protecting people from getting sick, the immune system has to be primed to make those antibodies.

That's the job of something called an adjuvant.

"The definition of [an] adjuvant is something you add to enhance, in the case of immunity, the immune response," says Gregory Glenn, president of research and development at Novavax, one of the companies that has received money from Operation Warp Speed.

Vaccines essentially trick the body into making an immune response to a specific virus or bacterium, so if something dangerous comes along, the immune system will be prepared.

But before it can prompt a response to a specific virus, the immune system has to be made ready.

"When you inject a vaccine, the first immune cell that's of importance is a dendritic cell," Glenn says.

Dendritic cells are part of what's called the innate immune response. These cells will respond to anything foreign that enters the body, the coronavirus included.

Continue reading "Aluminum is a Secret Sauce!" »


Interview with Prof Chris Exley on People Behind the Science

Podcast_channel_artworkFrom Professor Chris Exley:

In April 2020, I agreed to a telephone interview with Marie McNeely, the co-founder of an organisation called People Behind the Science (http://www.peoplebehindthescience.com/). The interview took place in early May 2020 to the apparent satisfaction of all concerned. In late June 2020, I received an email from Michael Green, also a co-founder of People Behind the Science, telling me, without explanation, that my interview would not be broadcast on their podcast. Subsequent emails from myself asking for an explanation and asking for the return of a copy of the interview were completely ignored by Green. Only when my US legal representatives issued a demand letter for a copy of the tape of the interview was a reply from Green forthcoming. He agreed to send an mp3 copy of the interview to prevent legal action being taken against him. However, what he actually sent was not what I asked for. He sent a highly edited copy of the interview in which there are many gaps and all words spoken by Marie McNeely had been removed. This is the low-resolution interview tape that I received from Green. Perhaps, as you listen you can play, fill in the gaps? Make your own judgement as to whether anything I say on this version of the interview would warrant censorship. Rather it appears to me from everything that has gone on that I am the subject of censorship here and that someone has threatened Green and McNeely with some form of repercussion should they broadcast my interview on their podcast. Whatever the reason, People Behind the Science and specifically McNeely and Green, should be ashamed of their actions. They do not deserve the support of anyone listening to or contributing to their podcast in the future.

 


SafeMinds: Having an Aunt or Uncle with Autism May Put Children at Higher Risk of ASD

Safeminds 2018 logoRisk estimated at 3 to 5 percent vs. 1.5 percent in general population

According to new research from the National Institutes of Health (NIH), a child who has a parent with a sibling on the spectrum is more likely to be diagnosed with autism spectrum disorder (ASD) compared to the general population. The study, published in Biological Psychiatry, analyzed health records of approximately 850,000 children born in Sweden between 2003-2012. Using the Swedish National Patient Register and the Multi-Generation Register, information on ASD diagnoses in both the child and parental generations were recorded.

Close to 13,000 Swedish children ended up with an autism diagnosis, about 1.5 percent of the cohort. However, children whose mother had one or more siblings with autism were three times more likely to have ASD than the general population and children whose fathers had one or more siblings on the spectrum were twice as likely to be diagnosed with autism than the general population. The study considered the slightly higher autism risk rate of children from mothers who had a sibling with ASD to that of the fathers to be insignificant. The research also reported that the autism risk rate was not different if the parent had a brother versus a sister with autism.

Ultimately, the researchers found that 3 to 5 percent of children whose parents have a sibling on the spectrum also have autism themselves. This points to a 100 to 230% increased chance of developing the disorder compared to the 1.5 percent autism rate in the general population. According to the authors, this is the first epidemiological study to provide an autism risk estimate for children with aunts or uncles on the spectrum.

Continue reading "SafeMinds: Having an Aunt or Uncle with Autism May Put Children at Higher Risk of ASD" »


Beda Stadler Prof Emeritus Medical Faculty University of Bern: Coronavirus Why Everyone Was Wrong

Beda StadlerBeda M. Stadler, former Director of the University Institute of Immunology at the Insel Hospital in Bern, is emerited professor of Immunology from the Medical Faculty of the University of Bern. His major research interests were in basic research in the field of allergy and autoimmunity as well as applied research in the field of immunology.

As Vice President of the Commission for Technology and Innovation (CTI) Federal Department of Economic Affairs, Education and Research EAER Switzerland he was heading the life science team and was a member of the CTI Start-up & Entrepreneurship label board.

During his career he liked to express his scientific and rational views in public as a frequent guest speaker and columnist for various print media.

Posted on Medium.com: Coronavirus: Why everyone was wrong The immune response to the virus is stronger than everyone thought

The original article was published in the Swiss magazine Weltwoche (World Week) on June 10th. The author, Beda M Stadler is the former director of the Institute for Immunology at the University of Bern, a biologist and professor emeritus. Stadler is an important medical professional in Switzerland, he also likes to use provoking language, which should not deter you from the extremely important points he makes.

This article is about Switzerland and it does not suggest that the situation is exactly the same globally. I am advocating for local measures according to locale situations. And I advocate for looking at real data rather than abstract models. I also suggest to read to the end, because Stadler makes crucial points about testing for Sars-CoV-2.

The coronavirus is slowly retreating. What actually happened in the past few weeks? The experts have missed basic connections. The immune response against the virus is much stronger than we thought.

By Beda M Stadler

This is not an accusation, but a ruthless taking stock [of the current situation]. I could slap myself, because I looked at Sars-CoV2- way too long with panic. I am also somewhat annoyed with many of my immunology colleagues who so far have left the discussion about Covid-19 to virologist and epidemiologist. I feel it is time to criticise some of the main and completely wrong public statements about this virus.

Firstly, it was wrong to claim that this virus was novel. Secondly, It was even more wrong to claim that the population would not already have some immunity against this virus. Thirdly, it was the crowning of stupidity to claim that someone could have Covid-19 without any symptoms at all or even to pass the disease along without showing any symptoms whatsoever.

But let’s look at this one by one.

1. A new virus?

At the end of 2019 a coronavirus, which was considered novel, was detected in China. When the gene sequence, i.e. the blueprint of this virus, was identified and was given a similar name to the 2002 identified Sars, i.e. Sars-CoV-2, we should have already asked ourselves then how far [this virus] is related to other coronaviri, which can make human beings sick. But no, instead we discussed from which animal as part of a Chinese menu the virus might have sprung. In the meantime, however, many more people believe the Chinese were so stupid as to release this virus upon themselves in their own country. Now that we’re talking about developing a vaccine against the virus, we suddenly see studies which show that this so-called novel virus is very strongly related to Sars-1 as well as other beta-coronaviri which make us suffer every year in the form of a colds. Apart from the pure homologies in the sequence between the various coronaviri which can make people sick, [scientists] currently work on identifying a number of areas on the virus in the same way as human immune cells identify them. This is no longer about the genetic relationship, but about how our immune system sees this virus, i.e. which parts of other coronaviri could potentially be used in a vaccine.

So: Sars-Cov-2 isn’t all that new, but merely a seasonal cold virus that mutated and disappears in summer, as all cold viri do — which is what we’re observing globally right now. Flu viri mutate significantly more, by the way, and nobody would ever claim that a new flu virus strain was completely novel. Many veterinary doctors where therefore annoyed by this claim of novelty, as they have been vaccinating cats, dogs, pigs, and cows for years against coronaviri.

2. The fairy tale of no immunity READ MORE HERE


WHO's lead scientist Soumya Swaminathan places chief hope in Oxford and Moderna vaccines

image from www.fic.nih.govHaving systematically screwed up the hydoxychloroquine (HCQ) trials for the treatment of the Covid virus and otherwise prevented its general use, all of which likely ended up in countless unnecessary deaths (see Dr Meryl Nass's despairing assessment) the WHO are now turning their attention to the first crop of vaccines, created at reckless speed with new technologies. The WHO's chief scientist told Reuters on Friday:

GENEVA (Reuters) - AstraZeneca's <AZN.L> experimental COVID-19 vaccine is probably the world's leading candidate and most advanced in terms of development, the World Health Organization's (WHO) chief scientist said on Friday.

The British drugmaker has already begun large-scale, mid-stage human trials of the vaccine, which was developed by researchers at University of Oxford.

This week, AstraZeneca signed its tenth supply-and-manufacturing deal.

"Certainly in terms of how advanced they are, the stage at which they are, they are I think probably the leading candidate," WHO chief scientist Soumya Swaminathan told a news conference.

The Oxford vaccine has a shaky history, funded to the tune of £90m million by the British government and taxpayer, and already in manufacture in billions of doses, the human trials began in April amid false reports that the animal trials had been successful: the product is arguably commercially too big to be allowed to fail. It also has the advantage that its lead developer Andrew Pollard heads the committee that will advise the British government on its use. Admittedly, last week he was in an apparently non-committal mood in conversation with Prince William:

Prof Pollard highlighted HIV, a virus for which no vaccine has been found because it mutates, saying scientists' great fear was that coronavirus could be the same. In that case, he said 'there is nothing we could do apart from social distancing forever' - a prospect William described as 'frightening'.

Continue reading "WHO's lead scientist Soumya Swaminathan places chief hope in Oxford and Moderna vaccines" »


Further Anomalies of the Oxford Coronavirus Vaccine

image from upload.wikimedia.orgby John Stone

On 27 April a New York Times article reported excitedly the result animal trials of the Oxford Coronavirus vaccine:

"Scientists at the National Institutes of Health’s Rocky Mountain Laboratory in Montana last month inoculated six rhesus macaque monkeys with single doses of the Oxford vaccine. The animals were then exposed to heavy quantities of the virus that is causing the pandemic... But more than 28 days later all six were healthy, said Vincent Munster, the researcher who conducted the test.."

This would have been just as well because just four days earlier on 23 April Oxford Vaccine Group under the leadership of Andrew Pollard amid immense publicity had begun experimenting on human subjects. On 30 April a contract was announced with AstraZeneca to manufacutre the vaccine, promising to deliver an entirely new vaccine to the market at unprecedented speed by September. The only trouble was that when the results of the animal trial came to light in mid-May it was disclosed that on the contrary all the monkeys had  become ill. The Daily Mail reported:

"In the latest animal trials of the vaccine carried out on rhesus macaques, all six of the participating monkeys went on to catch the coronavirus.

"Dr William Haseltine, a former Harvard Medical School professor, revealed the monkeys who received the vaccine had the same amount of virus in their noses as the three non-vaccinated monkeys in the trial.

This suggests the treatment, which has already received in the region of £90 million in government investment, may not halt the spread of the deadly disease."

Haseltine also commented in Forbes:

"There is a second troubling result of the Oxford paper. The titer of neutralizing antibody, as judged by inhibition of virus replication by successive serum dilutions as reported is extremely low. Typically, neutralizing antibodies in effective vaccines can be diluted by more than a thousand fold and retain activity. In these experiments the serum could be diluted only by 4 to 40 fold before neutralizing activity was lost."

Manifestly, human testing proceeded both against an entirely misleading background, and prematurely - which poses the most serious ethical questions. And now that we know that though the product was defective everything ploughs on regardless - Oxford/AstraZeneca now have contracts for hundreds of millions of rounds of the vaccine from both the British and the United States government.The British government has both a huge financial investment in the product and a reputational one, but it may help that Prof Pollard is both an adviser to the British regulator and chair of the committee recommends vaccine for public use.

John Stone is UK Editor for Age of Autism.

 

 

 


Professor Chris Exley: Aluminium in human brain tissue

AluminumExcerpted from the Blog of Professor Chris Exley, worldwide expert on aluminum and its effects on the human brain.

###

We have now measured the concentration of aluminium in human brain tissue from over two hundred donors involving at least five different brain banks. This equates to several thousand individual brain tissue samples. We have information relating to sporadic and familial Alzheimer’s disease, multiple sclerosis, cancer, epilepsy and autism. If I am honest, I am slightly bemused when, correctly, the question is asked about brain aluminium content in ‘control’ tissues. Bemused because such a question does suggest that the presence of an established neurotoxin, known to cause dialysis encephalopathy, is perhaps ‘normal’ and not a cause for concern.

We recently asked the question as to how much aluminium in human brain tissue is too much ( https://link.springer.com/article/10.1007%2Fs00775-019-01710-0) and we described an experiment in the paper to answer this question. We now have the data from this new study on the aluminium content of brain tissue from donors with no known neurological impairment and no identifiable neurodegenerative disease. The results are published in Nature’s Scientific Reports (www.nature.com/articles/s41598-020-64734-6) and they are unequivocal.

Read more from Professor Exley at Aluminium in human brain tissue at The Hippocratic Post


April 4 Expert Panel on COVID-19 & The Vaccines To Follow

Panel
Thank you to our Anne Dachel for transcribing excerpts for our readers.  Anne says:

"This was one of the most informative and empowering talks I’ve ever listened to in all the years I’ve been working as an autism advocate. Every person concerned about what the COVID 19 pandemic will do to our medical freedom needs to hear these speakers and learn the truth about what’s coming. There is no walking away from this threat to our liberties."

April 4, 2020, Panel discussion the COVID 19 crisis and what a vaccine could mean to the American people.

https://www.youtube.com/watch?v=cV_QPwWxOX8&feature=emb_share&fbclid=IwAR04nwi-CfzHYrIIgE5U00Gt7Z9ZBeht8N-3xzUtsHziHNHr8BuAKO0X6VQ


Panelists:

Dr. Andrew Wakefield, Dr. Judy Mikovits, Del Bigtree, Ty and Charlene Bollinger, Robert Kennedy, Jr., Dr. Sherri Tenpenny, Dr. Rashid Buttar.

Here are excerpts from the discussion.

Charlene: “…the year 2020 was a big deal. … This is the year, if we don’t help people understand this critical issue we may loss our freedoms, and they may be able to come in and try …to force us into these vaccines. But we did not know what we were getting into….

“I was watching Tucker Carlson  [Fox, Tucker Carlson Tonight]. He’s actually had Bobby Kennedy on…  We couldn’t believe that mainstream media outlet was covering that. We felt like Tucker’s our friend…

“Last night…on Tucker Carlson Tonight … He had a guest and they talked about Operation Wrap Speed, the COVID vaccination where they’re literally going to pass through the trials that they should be doing. They’re going to skip all that safety measures to get to this vaccine. They’re going to have a hundred million ready to go. …

“The guest talked about this as if it’s a good thing, and Tucker Carlson who has interviewed our good friend Bobby Kennedy, ….  I was really letdown by the fact that Tucker Carlson allowed that guest to say that and didn’t dig in. …”

5:42 Kennedy: “There’s now eighty separate vaccine projects. Bill Gates has eight of them. Bill Gates is now the biggest vaccine producer in the world, bigger than any other company.

Continue reading "April 4 Expert Panel on COVID-19 & The Vaccines To Follow" »


A Letter to My Member of Parliament: THE CRITICAL NEED FOR TRANSPARENCY AROUND COVID-19 VACCINES

image from pbs.twimg.comby John Stone

This is  the letter I sent to my Member of of Parliament yesterday forwarding the excellent  letter to the UK's Secretary of Health and Social Care, Matt Hancock (pictured with Bill Gates),  by Robert Verkerk and Damien Downing:

Dear ------,

 
RE: THE CRITICAL NEED FOR TRANSPARENCY AROUND COVID-19 VACCINES    
 
I am forwarding the excellent letter (attached) to Matt Hancock by Robert Verkerk of the Alliance for Nautal Health International and Damien Downing of the British Society for Ecological Medicine requesting transparency over the introduction of any COVID-19 vaccines in response to the current crisis, and I would suggest that it is necessary for the Secretary of State to make clear undertakings rather than vague professions of good faith. The letter can be found here on-line [1]. 
 
It was well understood even in the 19th century how statistics could be distorted for political purposes, since when the methods have only become more sophisticated and ultimately potentially more obfuscating. The safety, usefulness and effectiveness of universal vaccines should have to be meticulously and transparently established, yet we advance at reckless pace. It is certain that none of the candidates will have long term testing and it is questionable who on the face of it they could sensibly be given to [2].
 
There are other matters of transparency which go beyond the Verkerk/Downing letter. For example, the unusual arrangement by which the Secretary of State is also the main shareholder in the Porton Down Lab (as is now well-known). It was distressing to see how the Secretary of State began pumping public money into the speculative Porton Down vaccine project in the early stages of the epidemic, while failing to ensure that the puplic were immediately protected [3] (we are now heading for the worst fatality rate of any country). On the 19 March Public Health England put out a statement that they no longer considered COVID-19 to be a high risk disease [4] and within a day we were facing lockdown. Not much more convincing, now, are tub thumping references to British innovation by the Business Secretary or the Prime Minister.

Continue reading "A Letter to My Member of Parliament: THE CRITICAL NEED FOR TRANSPARENCY AROUND COVID-19 VACCINES" »


A New Route for Harm: Autism in the New Paper by Exley and Mold

AluminumWe recently published the abstract of a new paper by Exley and Mold 'Imaging of aluminium and amyloid β in neurodegenerative disease' which in particular offers new evidence ralating to the possible etiology of  autism. Prof Exley has elaborated:

"...the novel finding was the deposition of amyloid-beta and especially its presence in the vasculature similar to what is called cerebral amyloid angiopathy (CAA) in Alzheimer's disease. CAA could be interpreted as evidence of a toxin in the blood 'attempting' to cross the blood brain barrier to gain entry to brain tissue. CAA along with amyloid beta deposits in parenchyma does very much suggest brain damage and its presence in young brain donors is very surprising. It does raise the question if there are similarities between what is happening in brain tissue in autism and neurodegenerative diseases such as Alzheimer's disease."

It is stated in the paper:

"Our observations of amyloid β-like deposits in autism brain tissue are novel and may suggest neuropathology similar to that seen in CAA. We identified several examples of CAA in autism brain tissue as well as deposits of amyloid β in β sheet conformations in parenchymal tissues...Previous research identified diffuse deposits of amyloid β in brain tissue in older individuals with autism (39 and 50 years of age)...while herein amyloid β in β sheet conformations was confirmed in individuals with autism aged, 14, 15, 22, 33, 44 and 50 years of age.

Recently the non-amyloidogenic pathway of metabolism of amyloid precursor protein has been implicated in autism...while our observations suggest that the amyloidogenic pathway may also be important..."

It is obviously vital that this discovery is further investigated. Read the full paper here.

 


Imaging of aluminium and amyloid β in neurodegenerative disease

AluminumHeliyon, Science Direct

ChristopherExley, Matthew J.Mold

The Birchall Centre, Lennard-Jones Laboratories, Keele University, Staffordshire, United Kingdom

Received 10 December 2019, Revised 16 March 2020, Accepted 21 April 2020, Available online 25 April 2020.

https://doi.org/10.1016/j.heliyon.2020.e03839

Imaging of aluminium and amyloid β in neurodegenerative disease

Abstract

Objectives

Recent research has confirmed the presence of aluminium in human brain tissue. Quantitative analyses suggest increased brain aluminium content in a number of neurodegenerative diseases including familial Alzheimer's disease, congophilic amyloid angiopathy, epilepsy and autism. Complementary aluminium-specific fluorescence microscopy identifies the location of aluminium in human brain tissue and demonstrates significant differences in distribution between diseases. Herein we combine these approaches in investigating associations between aluminium in human brain tissue and specific disease-associated neuropathologies.

Methods

We have used aluminium-specific fluorescence microscopy, Congo red staining using light and polarised light and thioflavin S fluorescence microscopy on serial sections of brain tissues to identify co-localisation of aluminium and amyloid β and tau neuropathology.
Results

A combination of light, polarised and fluorescence microscopy demonstrates an intimate relationship between aluminium and amyloid β in familial Alzheimer's disease but not in other conditions and diseases, such as congophilic amyloid angiopathy and autism. We demonstrate preliminary evidence of amyloid β pathology, including associations with vasculature and parenchymal tissues, in autism in tissues heavily loaded with aluminium.

Conclusion

We suggest that complementary aluminium-specific fluorescence microscopy may reveal important information about the putative toxicity of aluminium in neurodegenerative and neurodevelopmental disorders.


FREE From Dartmouth Medical School Trained Dr. Paul Thomas COVID-19: The Life Saving Strategies the News Media Will Never Tell You

Dr Paul Covid Book
Thank you to Dr. Paul Thomas, MD for offering free downloads of his book COVID-19: The Life Saving Strategies the News Media Will Never Tell You.

Dr. Paul Thomas (affectionately known as “Dr. Paul”) received his MD from Dartmouth Medical School and completed is pediatric residency at the University of California, San Diego.

​Dr. Paul is a board-certified fellow of the American Academy of Pediatrics. FAAP. He is also trained in Integrative and Holistic Medicine. He is also a diplomate of the American Board of Addiction Medicine. ABAM.

Click HERE to register for your free copy today.

Dr. Thomas has over 1.2 million YouTube subscribers. Amazon banned the sale of this book on their site.  


MIT Technology Review: How does the coronavirus work?

MIT reviewExcerpted from the MIT Technology Review May 2020 issue:

How does the coronavirus work? What it is, where it comes from, how it hurts us, and how we fight it.

By Neer Patel

What is it?

A SARS-CoV-2 virion (a single virus particle) is about 80 nanometers in diameter. The pathogen is a member of the coronavirus family, which includes the viruses responsible for SARS and MERS infections. Each virion is a sphere of protein protecting a ball of RNA, the virus’s genetic code. It’s covered by spiky protrusions, which are in turn enveloped in a layer of fat (the reason soap does a good job of destroying the virus).
Where does it come from?

Covid-19, like SARS, MERS, AIDS, and Ebola, is a zoonotic disease—it jumped from another species to human hosts. This probably happened in late 2019 in Wuhan, China. Scientists believe bats are the likeliest reservoir; SARS-CoV-2’s closest relative is a bat virus that shares 96% of its genome. It might have jumped from bats to pangolins, an endangered species sometimes eaten as a delicacy, and then to humans.

How does it get into human cells?

Continue reading "MIT Technology Review: How does the coronavirus work?" »


British Government Plays With Fire Over COVID-19: Enter Prof Pollard

image from en.wikipedia.orgby John Stone

Next week Over Vaccine Group begin human testing for a COVID-19 vaccine with a with a view to marketing by the autumn. The speed of the process may be accelerated by the fact that Professor Pollard who heads the OVG is also advisor to the the UK's licensing body, the MHRA, and chair of the JCVI, the body which recommends vaccines to the British schedule. He very likely also sits on the British government’s mysterious Scientific Advisory Group for Emergencies.  Age of Autism has been higlighting the manifold and apparently contradictory roles of Prof Pollard for more than four years. In 2014 as recently appointed chair of the JCVI he recommended Bexsero meningitis B vaccine of which he was lead developer to the UK infant schedule, leading to a sudden leap in its commercial prospects. Even the package insert discloses serious dangers for Bexsero including a 3 in 1000 risk of Kawasaki Disease for an infant having three doses. 

While Pollard and likely the British government's plans rush forward many scientists have questioned either the wisdom of the COVID-19 vaccine or how fast one could be brought to the market. On the present time scale we will know nothing of the long term effects. Tests will be carried on healthy people 18-55 but rolled out for children, the sick and the elderly. It will be trialled against "a control injection" not genuine placebo, (in fact a Men ACWY vaccine). At present we do not even know if the disease itself results in long term immunity or any immunity against all the other mutations which are beginning to proliferate. Meanwhile, the OVG promotes discussion about whether vaccination should be made compulsory. Indeed, if it were it would be Prof Pollard's committee which would decide what every man, woman and child in the United Kingdom would receive, and would not be able to refuse.

This is Pollard’s most recent disclosure in the JCVI minutes:

Professor Pollard receives no personal payments from the manufacturers of vaccinesHe is Director of the Oxford Vaccine Group in the Department of Paediatrics, University of Oxford and has current research funding from the Bill and Melinda Gates Foundation, the National Institute for Health Research, the European Commission, Medical Research Council, Wellcome Trust, InnovateUK, Meningitis Research Foundation, and the Global Alliance for Vaccines and Immunisation. Hechairs the scientific advisory group on vaccines for the European Medicines Agency and is a memberof WHO’s SAGE.Other investigators in the Department conduct research funded by vaccine manufacturers and theDepartment has received unrestricted educational grant funding for a three-day course on paediatricinfectious disease from Gilead, and GSK in June 2019.

While it is inevitable that any scientist is going to be an enthusiast for is or her own research the long term indifference of the British government to traditional checks and balances is deeply concerning, and no less so at this difficult time. 


Recruitment begins for a clinical trial of a COVID-19 vaccine led by Andy Pollard

andrew pollard

Professor Andrew Pollard, Vice Master of St Cross College, is the Chief Investigator on a new study developing a possible vaccine for COVID-19. The 'ChAdOx1 nCoV-19' vaccine, as it is called, was developed by a team of University of Oxford researchers based on an adenovirus vaccine vector. A collaborative team from the Jenner Group and the Oxford Vaccine Group is now recruiting over 500 healthy volunteers for clinical trials of the vaccine. While applications for volunteers have closed, those interested in volunteering for future COVID-19 studies can register interest here.

Pollard is one of a team of academics, which includes himself, Professor Sarah Gilbert, Professor Teresa Lambe, Dr Sandy Douglas and Professor Adrian Hill, who began the project on Friday 10 January 2020. Pollard said, ‘Starting the clinical trials is the first step in the efforts to find out whether the new vaccine being developed at Oxford University works and could safely play a central role in controlling the pandemic coronavirus that is sweeping the globe.’

You can read more about the study here.

Riley Lewis

7 April 2020


Aluminium in Brain Tissue in Non‑neurodegenerative/ Non‑neurodevelopmental Disease: A Comparison with Multiple Sclerosis

Annette_Funicello_Former_Mouseketeer_1975Note:  In 1993, my husband won a sales award with his company and we were able to take a trip for four days. I chose DisneyWorld in Orlando. We stayed at the elegant Victorian hotel. One afternoon, I went into a ladies room in the lobby and behind me, in walked in Annette Funicello, with a lucite cane that was filled with glitter. I'll never forget it. We were in the ladies room, which meant we had business to conduct, and I didn't want to embarrass Ms. Funicello.  But I had to say SOMETHING. This was America's Sweetheart! I'd watched her beach movies. I knew she was the most famous Mouskateer.  I'm proud of what came out of my mouth! I said, "Oh, Ms. Funicello, now I really feel like I am in DisneyWorld because I saw  you."  She smiled at me. Funicello died at age 70 from MS. This beautiful girl, gorgeous woman, was destroyed by the disease.

I tell you this because when we read science, like this study from Chris Exley and his colleagues, the conclusions affect real lives. I tell you this, why?

"Because we like you."  M-O-U-S-E.

Vol.:(0123456789)1 3
Exposure and Health https://doi.org/10.1007/s12403-020-00346-9
ORIGINAL PAPER
|
Aluminium in Brain Tissue in Non‑neurodegenerative/Non‑neurodevelopmental Disease: A Comparison with Multiple Sclerosis

C. Linhart1 · D. Davidson2 · S. Pathmanathan2 · T. Kamaladas2 · C. Exley3Received: 5 October 2019 / Revised: 7 February 2020 / Accepted: 15 February 2020 © The Author(s) 2020

Abstract

Human exposure to aluminium is a burgeoning issue. The brain is a sink for systemically available aluminium and a putative target of neurotoxicity. An increasing number of studies continue to confirm the presence of aluminium in human brain tissue though primarily in relation to donors who have died of a neurodegenerative or neurodevelopmental disorder. Herein, we have measured aluminium in brain tissue in donors who died of a specific disease or condition though without showing any neurodegeneration. The donors were diagnosed as not suffering from multiple sclerosis. Herein, these novel data are compared with recent data on aluminium in brain tissue in multiple sclerosis. Brain tissues from all four lobes were obtained from the Multiple Sclerosis Society Tissue Bank. Tissues were digested using microwave-assisted acid digestion and their aluminium content was measured by transversely heated graphite furnace atomic absorption spectrometry. Both are established methods in our laboratory. Detailed statistical analyses were used to compare new data with recent data for multiple sclerosis. Aluminium was found in brain tissue in each donor with a high proportion of measurements (189/291) being below 1.00 μg/g dry weight. The data for all cases (median and IQR) were 0.74 (0.48–1.28), 1.23 (0.62–1.63), 0.84 (0.45–1.14) and 1.01 (0.62–1.65) μg/g dry weight for occipital, parietal, temporal and frontal lobes, respectively. There was a statistically significant positive correlation between aluminium content of brain tissue and the age of donor. Comparison of data for this non-multiple sclerosis group with brain aluminium data for donors dying with a diagnosis of multiple sclerosis showed that the latter had a statistically significant higher content of brain aluminium. The data reinforce a previous conclusion that the aluminium content of brain tissue in multiple sclerosis is elevated and support the suggestion that human exposure to aluminium may have a role to play in the aetiology of multiple sclerosis. Keywords Human exposure to aluminium · Aluminium in brain tissue · Aluminium in multiple sclerosis · Aluminium and neurodegenerative disease · Aluminium and neurodevelopmental disease  Read the paper here.


The Latest Autism Gene Study: NIH Director Collins Hails Deliberate Waste of Time, Money and Lives...

image from encrypted-tbn0.gstatic.comBy John Stone

In a short article in Southern Maryland Chronicle a few days ago the Head of the National Institutes of Health, Francis Collins, hailed the latest autism gene study under the title 'Largest-Ever Genetic Study of Autism Yields New Insights'. Perhaps the message here is that in order to fight crime the government has decided to investigate the victims not the perpetrators (actually it has been doing this for three decades). In 2006 as Head of the Human Genome Project Collins told Congress:

"But genes alone do not tell the whole story. Recent increases in chronic diseases like diabetes, childhood asthma, obesity or autism cannot be due to major shifts in the human gene pool as those changes take much more time to occur. They must be due to changes in the environment, including diet and physical activity, which may produce disease in genetically predisposed persons. Therefore, GEI (the Genes and Environment Initiative) will also invest in innovative new technologies/sensors to measure environmental toxins, dietary intake and physical activity, and using new tools of genomics, proteomics, and understanding metabolism rates to determine an individual's biological response to those influences."

References on-line to GEI seem to peter out round about 2008 (perhaps they were in danger of finding something). So, 14 years ago Collins warned that there would be no material result from this kind of research and it is what the government have been doing ever since, more or less as an employment scheme (typically, the new study boasts nearly two hundred authors). As Eisenhower said to no avail in his farewell speech six decades ago:

"Today, the solitary inventor, tinkering in his shop, has been overshadowed by task forces of scientists in laboratories and testing fields. In the same fashion, the free university, historically the fountainhead of free ideas and scientific discovery, has experienced a revolution in the conduct of research. Partly because of the huge costs involved, a government contract becomes virtually a substitute for intellectual curiosity....

"The prospect of domination of the nation's scholars by Federal employment, project allocations, and the power of money is ever present and is gravely to be regarded.

"Yet, in holding scientific research and discovery in respect, as we should, we must also be alert to the equal and opposite danger that public policy could itself become the captive of a scientific/ technological elite."

Now - with whatever insights their may be into gene risk association or even patterns of damage - is that all the NIH have really succeeded in doing is  generating  a lot more data: the new study is not only "the largest ever" it is "the largest-ever" in NIH speak (and with a huge cast), but in terms of government approved science we are not an inch nearer discovering what is driving the autism epidemic, just as Collins told Congress it would not all those years ago: it is all one giant step for mankind to nowhere. Meanwhile, the autism rate in schools is perhaps 4 or 5 times higher than it was then: it is rather hard to tell because NIH and CDC have failed to monitor it in any systematic way.

When I started out on this trail I recall a meeting at a freezing local church hall in early 1997 addressed by Paul Shattock, now of the ESPA Autism Research Unit, Sunderland. One of the many and terrible things Paul told us was that 90% off the funding into the causes of autism was being swallowed by useless gene research, meanwhile the problem was ten times as bad as ten years before. He foretold exactly was going to play out. How appalling and cynical this charade has been.

If you want to turn a disaster into a catastrophe and catastrophe into a cataclysm send for Collins!!!

John Stone is UK and European Editor, Age of Autism

 

 

 

 

 

 

Editor of Age of Autism

 

 


Coronavirus Can Be Caused By Viral Interference, A Known Result Of Flu Vaccines

Science post imageNews and articles about CORONAVIRUS are everywhere but our article, here on Age Of Autism, may be much different from what we are reading and seeing elsewhere.  It is interesting to observe the business side of all of this talk of health.  This from Business Insider, for example:

The flu is a far bigger threat to most people in the US than the Wuhan coronavirus. Here's why.

Although the CDC considers this coronavirus (whose scientific name is 2019-nCoV) to be a serious public-health concern, the agency said in a statement Friday that "the immediate health risk from 2019-nCoV to the general American public is considered low at this time."

A graver health risk for Americans — not just right now, but every year — is the flu….."When we think about the relative danger of this new coronavirus and influenza, there's just no comparison," William Schaffner, a vaccine expert at Vanderbilt University Medical Center, told Kaiser Health News (KHN). "Coronavirus will be a blip on the horizon in comparison. The risk is trivial."....So far, experts report that the median age of those who have died from the Wuhan coronavirus is around 75. Many of these individuals had other health issues like high blood pressure, diabetes, and Parkinson's disease…..Currently, the fatality rate for the coronavirus is about 3%. 

While the flu's fatality rate is lower than that, the CDC is still far more concerned about protecting Americans from influenza.

And there you have it.  Like Ralphie in A Christmas Story, it’s all about selling Ovaltine, but in this case, it’s the flu vaccine, which can be ineffective, we are told https://www.scientificamerican.com/article/flu-vaccine-selections-suggest-this-years-shot-may-be-off-the-mark/ .  As a result, you can bet lots of money is being lost and it sure looks like this virus in China has become a good excuse to get rid of these flu vaccines.  Another business piece that is obviously revving up, is to invent a coronavirus vaccine.

Honestly, just reading up on both influenza and coronavirus brings up some interesting reading.  For starters, it appears in China, that this year, there were twice as many flu shots being given:

Continue reading "Coronavirus Can Be Caused By Viral Interference, A Known Result Of Flu Vaccines" »


Negative Efficacy: UK Cervical Cancer Rate Rising in Teens Vaccinated for HPV

CevarixzImagine the horror of learning your young daughter has cervical cancer, once a rare disease, after having trusted that the HPV vaccine would prevent this disease.

From Children's Health Defense:

Bombshell Study Questioning HPV Vaccine Efficacy Appears as the UK’s Cervical Cancer Rates Rise in Young

Human papillomavirus (HPV) vaccines hit the global marketplace in the mid-2000s. From the start, public health agencies enthusiastically promoted HPV vaccination as the “best way to protect [young people] against certain types of cancer later in life.” However, a blistering new study by British researchers—and new data showing that cervical cancer rates are surging in British 25- to 29-year-olds—raise numerous questions about officials’ inflated claims. The study’s results indicate, instead, that the jury is still out on whether HPV vaccination is effective.

The question is far from academic because, prior to Britain’s introduction of HPV vaccination in 2008, cervical cancer rates had been trending sharply downward. In fact, between the late 1980s and mid-2000s, cervical cancer rates halved. Now, Britain’s leading cancer research charity (Cancer Research UK) reports a steep 54% rise in cervical cancer in one of the very age groups that first received the vaccine.

The 2020 study, published in the Journal of the Royal Society of Medicine, critically appraises twelve published randomized controlled trials that HPV vaccine makers GlaxoSmithKline and Merck used to buttress assertions about their vaccines’ efficacy (Cervarix and Gardasil). The British authors do not beat around the bush in presenting their conclusions, which include the following:

  • The trials’ questionable methodology generated “uncertainties” so significant that they undermine claims of efficacy.
  • The ages of the women who participated in the trials were not representative of the younger adolescents who constitute HPV vaccination’s primary target groups.
  • The studies used highly restrictive criteria to exclude many potential participants, limiting the trials’ “relevance and validity for real world settings.” (During Science Day presentations for the Jennifer Robi vs. Merck and Kaiser Permanente Gardasil lawsuit in January 2019, Robert F. Kennedy, Jr. made the same point, describing the “elite club of superheroes” who constituted the study group and noting that Merck purged anyone with the slightest vulnerabilities to the vaccine or its ingredients despite the fact that the vaccine would ultimately be marketed to girls with the very vulnerabilities excluded during the clinical trials.)
  • The trials used “composite and distant surrogate outcomes” that essentially made it “impossible to determine effects on clinically significant outcomes.” The authors explain that the surrogate outcomes used (forms of cervical dysplasia called CIN1 and CIN2) often regress on their own “and are of limited clinical concern.” They also note that different forms of cervical dysplasia each have “their own different natural histories, prevalence and incidence and strength of association with cancer.” Lumping together vastly different forms of dysplasia into the trials’ composite surrogate endpoints, therefore, was “problematic.”

    Read the full reports at Children's Health Defense here.